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Abstract 
Oleaginous yeasts are promising organisms for the production of lipid-based chemicals 
and fuels from simple sugars. We chose oleaginous yeast Rhodosporidium toruloides for the 
production of lipid-based products, because this oleaginous yeast natively produces lipids at high 
titers and can grow on glucose and xylose. However genetic tool for this host is very limited. We 
successfully transformed R. toruloides using Agrobacterium tumefaciens mediated 
transformation. We engineered two R. toruloides strains for increased lipid production by 
over-expressing the native acetyl-CoA carboxylase and diacylglycerol acyltransferase genes. Our 
best strain RT880-AD, derived from IFO0880, was able to produce 16.4±1.1 g/L lipid from 70 
g/L glucose and 9.5±1.3 g/L lipid from 70 g/L xylose in shake-flask experiments.  
Next, in order to further improve lipid production in R. toruloides, we explored more 
genetic engineering routes. We found over-expressing  malic enzyme and stearoyl CoA 
desaturase could improve lipid production 23% and 28 % in R. toruloides IFO0880 strain, but 
over-expression of glycerol-3-P dehydrogenase and pyruvate carboxylase failed to improve lipid 
titers. Deletion of peroxisomal structure gene PEX10 decreased overall biomass growth and lipid 
titer as well. Over-expressing stearoyl CoA desaturase improved lipid production further 13% in 
shake-flask cultures from strain RT880-AD, where ACC1 and DGA1 were also over-expressed. 
Malic enzyme over-expression, on the contrary, decreased lipid production from RT880-AD 
strain. The triple over-expression strain RT-ADS (ACC1, DGA1 and SCD) achieved 89.4 g/L 
lipid in fed-batch bioreactor, representing 396% increase from IFO0880 negative control strain 
and 42% increase from RT880-AD. The production rate for RT880-ADS was 5.0 times the rate 
in RT880-N and 1.4 times the rate in RT880-AD. These work represents one of the first 
metabolic engineering in R. toruloides and establishes this yeast as a new platform for 
iii 
 
production of lipid-derived products. 
On the other hand, we also explored another oleaginous yeast Yarrowia lipolytica, which 
previously has received more attention in the literature. It is both a citric acid producing and 
oleaginous yeast. During a medium optimization process, we found pH influences citric acid and 
lipid production in Y. lipolytica, and its effects on the citric acid and lipid were opposite. We then 
used pH as the tuning parameter to investigate how carbon flux distributes into these two 
different pathways. From RNASeq data, we didn’t find significant overall elevated expression in 
lipid synthesis pathways at low pH when lipid production was favored. We proposed a model 
that transport limits citric acid secretion in acidic pH, because the reverse gradient for proton is 
too high between extracellular pH and intracellular (neutral) pH in more acidic medium to pump 
out proton. 
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Chapter 1: Introduction  
1.1 Motivation 
Biology is nature’s ultimate master for synthesis. Even the fossil fuel, which brings 
majority of our daily consumables, gasoline, plastics and etc., is also derived from ancient plant 
and algae biomass. No matter how long fossil fuel is predicted to last for, we cannot sit on this 
human being’s saving account forever. Therefore, from a biologist point of view, we can seek 
innovations from those natural synthetic pathways that have been existing since long time ago.  
In order to make uses of a natural biological synthesis pathway, different routes can be 
used. There is the in vitro route, which the proteins, namely the enzymes that catalyze certain 
reactions are purified and added to the reaction. Examples are the cellulases business (Bhat and 
Bhat, 1997; Himmel et al., 1999). Similarly, enzymes can also be produced in a convenient host, 
such as Escherichia coli and its crude lysate will be used, instead of the purified protein. The 
further convenient way is to start from harvesting the protein synthesis machineries including 
ribosomes and charged tRNAs, and then add synthetic DNA, which encodes the wanted enzymes 
(Swartz, 2012). In this way, reaction pathways can be custom designed in a much faster and high 
throughput way. All these in vitro routes have the advantages of flexibility and not host 
dependent, but they usually have high costs for manufacturing these proteins/enzymes.  
The other route, the more common one, is fermentation. In this route, the enzymes are 
encoded in the microbes’ genome (less commonly in vectors), expressed and fulfilled the 
reactions during the fermentation. The only raw materials are the feedstock, nutritional 
supplements, certain gas and the microorganisms. Fermentations are scalable, requiring much 
less expensive material compared to the in vitro way. Also the microorganism strains are easier to 
maintain and propagate. Fermentation has a long history and still occupies a great portion of 
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many industries such as alcoholic beverages, bio-ethanol, citric acid and amino acids, antibiotics 
and etc. (Du et al., 2011; Zhao and Tan, 2015).   
For the scope of this thesis work, our target product is biodiesel and the fermentation 
product is lipid. Lipid is composed of glycerol backbone and (usually) long chain (16-18) fatty 
acid esters . These fatty acid can be transesterified into fatty acid methyl or ethyl esters, which 
resemble closer to the hydrocarbon molecules in diesel (Mata et al., 2010; Meher et al., 2006). 
Therefore these fatty acid esters can be blended into diesel without modification of current diesel 
engines (Athenstaedt et al., 2006). The current biodiesel comes from transesterifying plant oil, 
such as soybean and sunflower oil in the US and Europe. The commodity soybean oil is 614-677 
US dollars per ton (as of Dec 2015), for sunflower oil the number is 1,020-1,050 US dollars per 
ton (www.indexmundi.com). The cost for yeast de novo oil production, based on Ratledge’s 
calculation is $3,000 per ton, excluding cost of feedstock, assuming 5 g glucose for 1 g lipid 
(Ratledge, 2008). 
Although the current economic calculation showed yeast lipid may not be favorable, our 
work to improve the production of lipid from simple sugars by yeasts still holds great potential 
for these reasons: 1) As the genetic tools are developed to manipulate pathways sufficiently 
enough and our understanding to the pathways are better, we can engineer these host 
microorganisms to produce higher value-added products. These include the polyunsaturated fatty 
acids, fatty acids with various chain-length, alcohols, alkanes/alkenes and etc. (Dellomonaco et 
al., 2011). These specially tailored molecules go beyond agricultural plant’s synthesis capability, 
yet can be made in microorganism. 2) Plant commodity prices fluctuate and if in the future, the 
demand for biodiesel increases, price of plant oil will rise. Thus it’s always wise to have a 
backup option behind. 3) In terms of carbon source for the fermentation, negative valued 
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feedstock could be of potential interest. This means the feedstock required extra steps to get rid 
of, i.e. they are waste from other agricultural/industrial processes (Meesters et al., 1996). 4) From 
an academic point of view, this work will add on to human being’s intellectual property and may 
one day lay the foundation for other metabolic engineering research. 
The motivation of our work is to improve the production of lipid by oleaginous yeast from 
simple sugars. This work has been focus on improving the product titer, yield and productivity to 
drive the cost down. In order to do so, we have to genetically engineer my host microorganisms 
towards better production of the target beyond its wild type ability. Further, we will scale up my 
fermentation from shake flask to bench-top bioreactors. And with process optimization, we will 
demonstrate my engineered strain did achieve higher metrics. 
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1.2 Oleaginous yeasts 
1.2.1 Model and non-model yeasts 
For historical and practical reasons, certain microorganisms become the model organisms. 
For example, Escherichia coli is the most common model bacterium (Bhat and Bhat, 1997); 
likewise, Saccharomyces cerevisiae is the most used and understood yeast (Jeffries and Jin, 2004; 
Ostergaard et al., 2000). Model organisms usually grow relatively fast, with the doubling time 
for E. coli about 20 minutes (Sezonov et al., 2007) and for S. cerevisiae 2 hours (Craig and 
Jacobsen, 1985). Model organism also have more genetic tools available. Their high efficiency 
transformation protocols are usually worked out (Becker and Guarente, 1991; Ito et al., 1983). 
Vectors, selective markers, constitutive and conditional promoters and etc. are also available. S. 
cerevisiae is especially known to have native high efficient homologous recombination system, 
thus enabling targeted knock-in and knock-out (Ma et al., 1987; Shao et al., 2009). Therefore 
these model organisms are great for the entry step to test a metabolic engineering strategy or to 
bring in and troubleshoot a heterogeneous pathway (Galanie et al., 2015; Yan et al., 2005). 
For some target molecules, model organism still is the workhorse for industrial 
fermentation, such as ethanol by S. cerevisiae. However, more and more non-model organism 
have attracted us for the choice of host organisms, because these non-model organisms can 
natively produce our target molecules at much higher yield and/or titer. Other times they are 
favored because they have a richer pool of the precursors for the target molecules. On the 
contrary, model organism might not favor and produce our target molecule, in this case the lipid, 
because they did not evolve towards this way. 
The difficulties working with non-model organism prompted out obviously: generally less 
is known, thus we do not have the protocol layout. Not all experiences leant from model 
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organism can apply successfully to non-model ones. In addition, genome sequences for many 
non-models are not revealed, nor exist their fully functionally annotated information. However, 
since next generation sequencing is developing rapidly, genome sequencing becomes easier and 
less expensive than ever (Shendure et al., 2004). The transcriptome can also been probed by this 
massively paralleled sequencing technology. With these, we are able to domesticate more and 
more non-models into our model organisms with dedicated work (Kahl and Endy, 2013). 
Oleaginous yeasts are great host for lipid and lipid based molecule production, because 
they are able to naturally accumulate lipid under certain nutrient conditions (Ageitos et al., 2011). 
Lipid is the building block for cell membrane, but it also serve as important energy storage 
materials (Sandager et al., 2002). Oleaginous yeasts divert the excess carbon sources into lipid, 
mainly as triacylglycerides, when certain other nutrient sources are limited, usually nitrogen 
source (Beopoulos et al., 2011; Ratledge and Wynn, 2002). Phosphor limitation is also observed 
to induce lipogenesis (Wu et al., 2010). Lipid is stored intracellularly into lipid body to be 
separated from the hydrophilic cytoplasm environment. Athenstaedt et al found that there were 
lipogenesis associated proteins located on the surface of lipid body, indicating that lipid synthesis 
and storage processes were highly linked and structurally coordinated (Athenstaedt et al., 2006). 
1.2.2 Biochemical pathway for storage lipid 
The biochemical pathway of storage lipid synthesis in oleaginous yeast has been 
elucidated in depth. Generally, the growth can be divided into two distinct phases: the growth 
phase and the lipid accumulating phase (Morin et al., 2011). In the growth phase, because all the 
essential nutrient sources are abundant, these yeast behave in a typical growth curve, non-lipid 
biomass is produced. After certain nutrient, in most studied case, nitrogen source is depleted, and 
importantly, carbon source is still in excess, these yeast transitions into the second phase, the 
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lipid accumulation phase (Ratledge and Wynn, 2002). The intracellular metabolism therefore 
undergoes a series of rewires: It is commonly believed that the depletion of NH4+ triggers the 
cleavage of AMP into IMP and NH4+ Papanikolaou and Aggelis, 2011 by AMP-desaminase ( ). 
This step can release extra NH4+
Evans and Ratledge, 1985
, but the decrease of AMP level in turn results in the 
deactivation of enzymes that that depend on AMP, in this case the isocitrate dehydrogenase 
(IDH), the enzyme responsible for converting isocitrate into α-ketogluterate in the tricarboxylic 
acid cycle in the mitochondria ( ; Papanikolaou et al., 2004) (Wynn et 
al., 2001). AMP is the alloteric activater of isocitrate dehydrogenase, for example in oleaginous 
yeast Yarrowia lipolytica (Morgunov et al., 2004b). The less activity in IDH causes the 
accumulation of isocitrate, which is in balance with citrate, by the enzyme acontinase. As the 
glycolysis continues to provide pyruvate, which is cleaved by pyruvate dehydrogenase in the 
mitochondria to provide acetyl-CoA into the TAC cycle, citric acid therefore starts to 
accumulates. The excess of citric acid starts to be transported out from the mitochondria into the 
cytosol by presumably citrate/malate shuttle (Evans et al., 1983). Next comes a critical step, the 
ATP-citrate lyase (ACL). This enzyme in the cytosol cleaves citrate into oxaloacetate and 
acetyl-coA at the cost of ATP (Boulton and Ratledge, 1981). This step is the opposite of citrate 
synthase in the TCA cycle. This ACL is usually highly expressed and active in oleaginous yeast 
(Boulton and Ratledge, 1981). This is also the key enzyme that differentiate between oleaginous 
and citric acid producing yeast. Theoretically, without the activity of this enzyme, citric acid will 
be accumulated without lipid producing. Next, as acetyl-CoA is the building block of fatty acid, 
the latter starts to kick in. Briefly summarizing what had happened during these TCA to cytosol 
event: the high level of acetyl-CoA in the cytosol ultimately comes from pyruvate, but has taken 
a long and detoured way through TCA cycle in the mitochondria.    
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Other than acetyl-CoA, another key ingredient for fatty acid synthesis is NADPH. Early 
studies implies that NADPH comes from transhydrogenase cycle (Wynn et al., 2001). This cycle 
works this way: pyruvate in the cytosol is carboxylated into oxaloacetate by pyruvate 
carboxylase (PYC) using ATP; oxaloacetate is converted into malate by malate dehydrogenase 
(MDH) using NADH; NADPH is generated by malic enzyme (ME) from converting malate back 
to pyruvate. The net change of this cycle is converting a NADH into a NADPH at the expense of 
an ATP. However recently studies shows this may not be the source of NADPH for some 
oleaginous yeasts (Ratledge, 2014). Wasylenko at al showed that in Yarrowia lipolytica, the 
majority NADPH source is pentose phosphate pathway (Wasylenko et al., 2015). By (13)C 
metabolic flux analysis, they showed that in a engineered strain where lipid was about twice as 
the wildtype, the flux through pentose phosphate pathway also doubled, whereas the flux through 
malic enzyme didn’t change.  
The source of NADPH matters because it will determine where the theoretical maximum 
yield draws the line. If calculated solely from the number of carbon, 100 g of glucose will yield 
33 gram of triacylglycerides (Ratledge, 2008). If the calculation involves NADPH and if the 
source is through transhydrogenase cycle, the number will drop to 31.6 gram; If NADPH comes 
from pentose phosphate pathway, the theoretical maximum will be 27.6% g per g of glucose 
(Ratledge, 2014). This may explain why in practical, the lipid yields usually sit between 20-22% 
(this includes the carbon built into non-lipid biomass) (Ratledge, 2008). 
With NADPH and acetyl-CoA, fatty acid synthesis moves on. Acetyl-CoA is first activated 
into malonyl CoA by acetyl-CoA carboxylase (ACC). This is the committing step for fatty acid 
synthesis. (Davis et al., 2000)Fatty acid synthesis is carried by fatty acid synthase complex (FAS). 
Yeast FAS belongs to Type I FAS, which is one big multi-domain complex(Schweizer and 
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Hofmann, 2004). Malonyl CoA is transferred onto acyl carrier protein (ACP) of this FAS 
complex. In the first cycle, acetyl group is condensed from acetyl-ACP onto malonyl-ACP, 
resulting acetoacetyl-ACP. The latter is reduced into 3-hydroxyacyl-ACP by ketoacyl-ACP 
reductase, using one NADPH. The latter was dehydrated by 3-dehydroxacyl-ACP dehydrase, 
resulting 2-enoyl-ACP. This is again reduced by enoyl-ACP reductase, at a cost of NADPH, 
yielding saturated fatty acyl-ACP. Then fatty acyl group is transferred from ACP onto 
condensing enzyme (CE). In the next N cycles, the fatty acyl-CE is condensed onto a new 
malonyl-ACP. After the fatty acid chain grows to usually 16 or 18 carbon length, fatty acyl-ACP 
is transferred to CoA by transacylase on the FAS, and/or further hydrolyzed by thioesterase, 
releasing free fatty acid.  
To store fatty acid, they are mainly incorporated into triacylglycerides (TAG). First fatty 
acid need to be activated into fatty acyl-CoA by fatty acyl-CoA synthetase (FAA) (Black and 
DiRusso, 2007). The first acyl chain is esterified with glycerol-3-phosphate catalyzed by 
glycerol-3-phosphate acyl transferase. The second acyl chain is added by 
1-acyl-sn-glycerol-3-phosphate acyltransferase. The third acyl chain addition is catalyzed by 
diacylglycerol acyltransferase on the sn-3 position. diacylglycerol acyltransferase is the final step 
of TAG formation. Beopoulos et al. tagged DGA1p with YFP and found it mostly located on the 
surface of LB (lipid body) (Beopoulos et al., 2009). This is also confirmed by Athenstaedt et al 
(Athenstaedt et al., 2006). In that work, they specifically extracted intact lipid body out of the 
cells and analyzed proteins within the LB. These enzymes glycerol-3-phosphate acyl transferase 
SCT1, 1-acyl-sn-glycerol-3-phosphate acyltransferase SLC1, diacylglycerol acyltransferase 
DGA1 were confirmed to be present in lipid body. This indicates that the lipid bodies grow by 
synthesizing more TAG on its surface.   
9 
 
1.2.3 Lipid degradation pathway 
Lipid degradation starts from releasing fatty acids from TAG. This is done by TAG lipases 
(Mullner and Daum, 2004). Free fatty acids are hydrolyzed from TAG, subsequently activated 
into fatty acyl-CoA and enter into β-oxidation (Alvarez et al., 2000). There are two types of 
β-oxidation: in peroxisome and in mitochondria. In peroxisome, saturated fatty acyl-CoA is first 
oxidized to form a double bond at C-2 position by fatty acyl-CoA oxidase, resulting in 
2-enoyl-CoA. Unlike S. cerevisiae only has one acyl-CoA oxidases, oleaginous yeast Candida 
tropicalis or Y. lipolytica have several acyl-CoA oxidases that have different chain-length 
specificity (Wang et al., 1999). Second, this newly formed double bond is hydrated by 2-enoyl 
CoA hydratase, forming 3-hydroxyacyl-CoA. Third, the 3-hydroxyacyl-CoA is further oxidized 
into 3-oxoacyl-CoA by a dehydrogenase. Second and third step is carried by one enzyme, the 
multifunctional enzyme (MFE) (Hiltunen et al., 1992). At the end of each cycle, thiolase comes 
in, cleaves an acetyl-CoA , leave the acyl-CoA with chain length minus two. Acetyl-CoA is used 
as energy source in TCA cycle or in the glyoxylate cycle.  
Mitochondrial β-oxidation has got very limited information in oleaginous yeast. Haddouche 
et al pointed out the existence of mitochondrial β-oxidation, because they knocked out the 
peroxisome MFE gene, but still detected the 3-β-ketoacyl-coA in Y. lipolytica (Haddouche et al., 
2011). Beopoulos had found acyl-CoA dehydrogenase, 2-enoyl-CoA hydratase and 
3-ketoacyl-CoA thiolase for mitochondrial β-oxidation (Beopoulos et al., 2011). 
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1.3 Yarrowia lipolytica, a modest lipid producer with genetic tools available 
1.3.1 The general physiology about Yarrowia lipolytica 
Oleaginous yeast Yarrowia lipolytica, an ascomycete yeast was isolated from dairy product 
such as cheese, or from oil field (Barth and Gaillardin, 1997). It has drawn research attention in 
these areas: 1) since it’s a dimorphic, meaning it exists as yeast-like or mycelium-like form, the 
factors influencing dimorphic transition has been revealed: pH, carbon and nitrogen source and 
etc (Ruiz-Herrera and Sentandreu, 2002). 2) Y. lipolytica has also been explored for 
bio-remediation purposes since it can metabolize hydrocarbon or lipids (Fickers et al., 2005). 3) 
Y. lipolytica is capable of secreting large amount of proteases, lipases (Destain et al., 1997; 
Gonzalez-Lopez et al., 2002). 4) It can also secrete large quantity of organic acid, such as citric 
acid, α-ketogluterate and pyruvate acid, therefore serving as an industrial workhorse (Morgunov 
et al., 2004a; Papanikolaou et al., 2002; Zhou et al., 2012).  
Several haploid strains of Y. lipolytica has been used by various groups. The strain CLIB122 
(also called E150) has been sequenced and annotated in depth (Dujon et al., 2004). The genome 
contains six chromosomes, total 20.5 Mb of DNA. The mitochondria DNA sequence is also 
available. GC content is 49.0%. There are total 7357 genes identified. The introns are not rich, 
about 13% of genes have one or occasionally two or more introns (Bon et al., 2003). Another 
series of strains, W29 and its auxotroph derivatives are more frequently used in genetic 
engineering of this host, because auxotrophy provides useful markers for genetic tools . There 
are several auxotroph derivatives from the wildtype W29 strain: Po1d (Leu−, Ura−, ΔAEP, Suc+), 
Po1e (Leu−, ΔAEP, Suc+, pBRc), Po1f (Leu−, Ura−, ΔAEP, ΔAXP, Suc+), Po1g (Leu−, ΔAEP, ΔAXP, 
Suc+ Madzak et al., 2000, pBR )( ). Po1f is recently genome sequenced (Liu and Alper, 2014). Its 
size is 20.3 Mb. Sequence data of Po1f shows its sequence is very similar to CIB122 in nature, 
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except long terminal repeat retrotransposon is absent, and one deletion in Chromosome A results 
in four ORFs missing, including two genes related to homologous recombination (Liu and Alper, 
2014).  
Y. lipolytica, same with other oleaginous yeasts, is obligate aerobic, meaning its growth is 
dependent on oxygen (Kamzolova et al., 2003). This indicates we have to culture Y. lipolytica 
with strict aerobic condition, such as low filling volume in test tube, relatively high (more 
importantly fixed) rotating speed in shake-incubator and relatively high dissolved oxygen 
settings in bioreactors.  
1.3.2 Y. lipolytica is an attractive organism for biofuel and value-added product 
Wildtype Y. lipolytica was able to accumulate lipid as its dry cell weight to 15-30% 
(Beopoulos et al., 2009; Beopoulos et al., 2008; Ratledge, 1991; Tai and Stephanopoulos, 2013). 
Therefore its de novo lipogenesis has attracted researchers to use it as host for lipid production. 
To improve the lipid content and titer, various routs have been proposed and validated. 
Beopolous et al deleted GUT2, POX1-6 to increase lipid yield (Beopoulos et al., 2008). Other 
deletion targets have also shown to increase lipid yields: the global transcriptional regulator 
SNF1(Xue et al., 2013), the peroxisome related protein PEX10 (Xue et al., 2013) (Blazeck et al., 
2014a), a global regulator MIG19 (Wang et al., 2013). Tai and stephanopoulos has boosted lipid 
yield by over-expressing key enzymes ACC1 and DGA1 in lipid synthesis (Tai and 
Stephanopoulos, 2013). In a following work by the same group, Qiao et al. over-expressed 
stearoyl-CoA desaturase (SCD) in addition to Tai’s design and achieved 3.5-5 lipid titer (Qiao et 
al., 2015). Blazek et al combined the over-expression of DGA1 and deletion of PEX10 and mfe1 
and was able to achieve up to 90% lipid content, 25 g/L lipid in Y. lipolytica (Blazeck et al., 
2014a). The same group also explored an evolutionary route to improve lipid production, where 
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Liu et al enriched cells with higher lipid content by selecting the more buoyant cells. They were 
able to improve lipid yield 55% more (Liu et al., 2015a). 
Not only the naturally accumulating lipid, Y. lipolytica is also great as a platform host for 
oleo-chemical production, since it has a big pool of acetyl-CoA and fatty acid. Rutters et al. were 
able to produce medium-chain fatty acids in Y. lipolytica by over-expressing medium-chain 
specific thioesterases (Rutter et al., 2015). Beopoulos et al. have successfully produced ricinoleic 
acid, a valuable material for chemical industry, by expressing a heterogenous Δ12-oleate 
hydroxylase (CpFAH12) in a Y. lipolytica strain where six POX genes and endogenous 
Δ12-desaturase (FAD2) and native triacylglycerol (TAG) acyltransferases (DGA1, DGA2, and 
LRO1) were deleted (Beopoulos et al., 2014). Dupont researchers successfully synthesized 
eicosapentaenoic acid (EPA), a value-added long chain unsaturated fatty acid previously 
produced from fish oil in Y. lipolytica. They produced 25% dry cell weight as EPA and 50% of 
fatty acid were EPA by combining deletion of PEX10 and over-expressing 41 copies of 19 
different genes (Xie et al., 2015; Xue et al., 2013; Zhu and Jackson, 2015). Metabolic 
engineering these complicated pathways often evolves complicated design, such as reducing 
competing pathways, deleting product degradation pathways, over-expressing various type of 
enzymes and balancing them. 
In addition to genetic approaches, process optimization often contributes greatly to the final 
titer and yield. In the previously mentioned work, they all achieved higher titers moving form 
shake-flask into bioreactor, where pH and dissolved oxygen can be tightly controlled. Kavšček et 
al. employed a pure process optimization strategy, where controlled fed-batch was used reduce 
citric acid secretion and reduced dissolved oxygen was used to improve lipogenesis, implicated 
from their computational flux balance analysis. They were able to increase lipid content 80% and 
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improve lipid yield 4-fold (Kavscek et al., 2015).  
1.3.3 Genetic tools development in Y. lipolytica 
For Y. lipolytica, convenient transformation methods are available. An electroporation 
protocol involving pretreating cells in 150 mM lithium acetate for 1 hour yielded transformation 
efficiency 2*104 Wang et al., 2011 colony forming units (CFU) per µg linear DNA ( ). An efficient 
one-step transformation protocol harvesting fresh cells from solid medium was also widely used. 
This one-step protocol was based on heat shock in 39 °C for 1 hour with dithiothreitol and 
poly(ethylene glycol) 4000. The transformation efficiency was 105
Chen et al., 1997
 CFU per g replicative plasmid 
( ). 
To express any protein, first step is to choose a functional promoter. A few native promoters 
were used to drive protein expression, such as FBAin, GPD, EXP, YAT, TEF, TEFin (Tai and 
Stephanopoulos, 2013; Xue et al., 2013). Noticeably, if there is a 5’ intron very close to the start 
codon (often times right after ATG), it is better to include the 5’ intron into the promoter design, 
such as TEFin versus TEF. The former is 17 times stronger than the latter (Tai and 
Stephanopoulos, 2013). This observation not only existed in Y. lipolytica but is agreeable in other 
eukaryotic hosts (Callis et al., 1987; Furger et al., 2002). Another promoter design is to fuse 
multiple copies of enhancers in front of a promoter (Blazeck et al., 2011; Madzak et al., 2000). In 
these ways, a collection of promoters varying in strength was created. 
Targeted deletion in this host is difficult. Homologous recombination efficiency is very low 
in this host, on the contrary to S. cerevisiae. In Y. lipolytica, the double strand break is usually 
repaired by non-homologous end jointing (NHEJ). If we want to knock out a gene by 
transforming the DNA with homologous flanking arms up and downstream a marker, we are 
expecting double cross over. Therefore the chance of targeted replacement is very low, 0-2 % 
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according to Verbeke et al.(Verbeke et al., 2013). What is worse is the random integration will 
dominate the transformants, thus making the colony verification extremely tedious. There are 
several smart ideas about improving the homologous recombination efficiencies.  Verbeke et al 
and Kretzschmar et al construct a ku70 defective Y. lipolytica strain and brought the targeted 
deletion efficiency to 43% - 85% (Kretzschmar et al., 2013; Verbeke et al., 2013). KU70-KU80 
heterodimer is an essential protein complex for NHEJ (Walker et al., 2001). Deletion of KU70 
improved homologous recombination ratio, but deletion of KU80 was not obvious in Y. lipolytica 
(Kretzschmar et al., 2013). Tsakraklides et al had shown that by resting cell cycle at S phase, 
homologous recombination efficiency can also be improved. They tested several yeast strains, 
and in Y. lipolytica the targeted replacement could be 4 - 9 % with only 40 bp flanking length 
(Tsakraklides et al., 2015). 
Very recently CRISPR-Cas9 system was successfully developed in Y. lipolytica (Schwartz et 
al., 2016). Schwartz et al expressed the single guidance RNA (sgRNA) by a hybrid PolIII-tRNA 
promoter. By the native maturation of the tRNA, sgRNA is also processed maturely. They 
expressed codon optimized Cas9 by UAS1B8-TEF promoter. They were able to get higher than 
92% homologous recombination rate with this tool. And in a ku70 strain, the homologous 
recombination is 100%. With CRISPR-Cas9, not only single deletion is much easier, multiple 
deletions and multiple knock-in (for over-expressing) will also be much easier, since this is a 
markerless method. This will surely bring the speed of metabolic engineering of Y. lipolytica to 
the next phase.  
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1.4 Rhodosporidium toruloides, the even higher lipid producing yeast 
1.4.1 Why Rhodosporidium toruloides is attracting 
We have also turned to another oleaginous yeast Rhodosporidium toruloides, because R. 
toltuoides is able to accumulate lipid to even higher content and total titer. Y. lipolytica wildtype 
can accumulated lipid 15-30% of dry cell weight, but R. toruloides was reported to accumulate 
nearly 70% lipid content under tightly controlled bioreactor conditions (Li et al., 2007; Ratledge 
and Wynn, 2002). Among the choices of lipid producers in oleaginous yeast, R. toruloides is one 
of the highest candidates (Papanikolaou and Aggelis, 2011). Another oleaginous yeast Lipomyces 
starkeyi, which is about similar level as R. toruloides, is naturally a polyploid. Therefore L. 
starkeyi is more difficult as a lab host microorganism.  
Not only R. toruloides has the advantage of having haploid strain, but also it is able to utilize 
a broad range of carbon substrate, such as glucose, xylose, cellobiose, sucrose, glycerol and etc 
(Bommareddy et al., 2015; Xu et al., 2012). Therefore it is a good candidate for utilizing 
lignocellulosic biomass, since the latter consists of a mixer of 6-carbon and 5-carbon 
polysaccharides. R. toruloides also metabolizes fatty acids in our hand (data not shown).  
R. toruloides is red basidiomycetous, isolated from wood pulp. It is also a budding yeast. 
The prefix “Rhodo” means red. R. toruloides got this red color because it naturally produces the 
pigment carotenoid (Dias et al., 2015; Lee et al., 2016).  
1.4.2 Genetic tools development in R. toruloides 
R. toruloides genome sequences are available in several strains. The best annotated version 
is the NP11 strain, because this version combines DNA genome sequencing data with RNA 
transcriptome sequencing data, therefore the introns and exons were well recognized (Zhu et al., 
2012). This NP11 strain is a haploid, sporulated from a diploid strain Y4 (Zhu et al., 2012). The 
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Y4 strain was derived originally from the mating offspring from two opposite mating type strains 
IFO0880 and IFO0559 (Zhu et al., 2012). According to Zhu et al. R. toruloides NP11 genome 
consists of 16 chromosomes, total size is 20.2 Mb. Introns are predominant, 97.1% genes have at 
least on intron. One specific metric for R. toruloides is the GC content. The total GC content for 
the genome is 62.03%, with the coding sequence 63.12% GC.  
The strain we are working with is IFO0880 and IFO0559. We chose the two because they are 
related to NP11, and they are the opposite mating type. We started to use NP11 as the reference 
genome to build primers, but quickly found out that different from IFO0559, IFO0880 genome 
sequence contains too many single nucleotide variations so we cannot use NP11 as the reference 
genome. Our collaborators Dr. Jeffrey Skerker, Dr. Matthew J. Maurer 
Different from Y. lipolytica, the more frequently studied yeast within the oleaginous yeasts 
group, R. toruloides is even less explored. First, transforming R. toruloides is challenging. 
Electroporation or chemical transformation didn’t work well in this host. This is also why there 
are so few publications in R. toruloides. Liu et al. first successfully transformed R. toruloides by 
a method commonly used in plant, the Agrobacterium tumefaciens mediated transformation 
(ATMT) (
from Prof. Adam Arkin 
group sequenced IFO0880 and IFO0559 together with a few other R. toruloides strains. These 
work made genetic engineering R. toruloides possible. 
Liu et al., 2013). Similarly, Abbott also employed ATMT to transformed 
Pucciniomycotina yeasts, in which R. toruloides is within this phylum (Abbott et al., 2013). 
Agrobacterium tumefaciens is a bacterium species that infects and induces gall formation in 
plants (Cangelosi et al., 1991). It does so by injecting and integrating its transferred DNA 
(T-DNA) into the host genome (Hooykaas et al., 1979). A. tumefaciens encodes its virulent genes 
responsible for the gene transfer on its own plasmid, and its injected T-DNA is bounded left and 
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right by a set of specific DNA sequences called left and right boundaries (Lazo et al., 1991). A. 
tumefaciens is a powerful tool for biotechnology because we can clone our custom designed 
DNA sequences into the left and right boundaries, and A. tumefaciens will deliver this foreign 
DNA into the host genome. Although A. tumefaciens naturally infect plants, it is shown to infect 
various strains of yeasts, bacterial or even mammalian cell lines (Kunik et al., 2001).  
Majority of literature about R. toruloides is about the characterization and cultivation of it, 
only a few involves genetic engineering. Liu and et al first expressed a codon-optimized 
fluorescent eGFP in R. toruloides (Liu et al., 2013). Later the same group engineered a D-amino 
acid inducible promoter from the D-amino acid oxidase gene (DAO1) promoter (Liu et al., 
2015b). They were also able to do targeted homologous recombination by deletion KU70 in R. 
toruloides, although the efficiency is still gene dependent: from 2.1% to 95.8% (Koh et al., 2014).  
Fillet et al. produced fatty alcohols by expressing a fatty acyl CoA reductase from Marinobacter 
aquaeolei VT8. They were able to achieve 8 g/L C16 and C18 fatty alcohols in bioreactors and 
80% of the fatty alcohols were secreted into the supernatant (Fillet et al., 2015). 
Clearly R. toruloides is far less developed. The lack of protein expression knowledge, 
absence of a replicative plasmids, and low efficiency of homologous recombination pose 
obstacles for genetic manipulation; the very long time of A. tumafaciens mediated transformation 
(from a pure plasmids to first R. toruloides colony on plate at least 7 days). Nevertheless, long 
growth period (about 9 days for 70 g glucose in shake flask and 14 days for 70 g xylose in shake 
flask in low nitrogen medium). But since it is able to accumulate large quantity of lipid, R. 
toruloides is great host for producing lipid-based molecules at higher titers and yields. From the 
biotechnology perspective, that matters the most.  
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1.5 Figures 
 
Figure 1.1 Microscopy picture of Yarrowia lipolytica. Red scale bar represents 10 micron. 
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Figure 1.2 Rhodosporidium toruloides colonies.(showing the red color and colony morphology) 
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Figure 1.3 Agrobaterium tumefaciens mediated transformation (ATMT). Binary plasmids 
encodes custom designed DNA, bounded out left boundary (LB) and right boundary (RB). 
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Chapter 2: Engineering Rhodosporidium toruloides for increased lipid 
production by over-expressing acetyl-CoA carboxylase and diacylglycerol 
acyltransferase1
2.1 Introduction 
 
Oleaginous yeasts are attractive organisms for producing lipid-related molecules, 
including biodiesel, adhesives, and high-value nutritional oils (Beopoulos et al., 2014; Blazeck et 
al., 2014b; Matthaus et al., 2014; Ratledge, 2004; Xue et al., 2013). The reason is that these 
microorganisms can accumulate vast stores of fatty acids, most commonly as neutral lipids in 
triglyceride form (Beopoulos et al., 2011; Ratledge and Wynn, 2002). These microorganisms 
generate lipid stores when carbon is in excess but other key nutrients, such as nitrogen, are scarce 
(Granger et al., 1993; Wu et al., 2010). Because these scarce nutrients only support limited cell 
growth, these microorganisms store excess carbon as neutral lipids within intracellular bodies 
(Beopoulos et al., 2009; Papanikolaou and Aggelis, 2011). From a biotechnology perspective, 
oleaginous yeast are intriguing as these lipid stores can represent over 70% of the dry weight of 
the cell (Ratledge and Wynn, 2002).    
The metabolic engineering of oleaginous yeast is still limited. Most work to date has been 
performed in Yarrowia lipolytica, which is the best-characterized oleaginous yeast (Barth and 
Gaillardin, 1997) and possesses the most advanced genetic tools (Blazeck et al., 2011; Blazeck et 
al., 2013; Chen et al., 1997; Fickers et al., 2003; Liu et al., 2014; Wang et al., 2011; Yamane et al., 
2008). A number of researchers, for example, have been able to improve lipid production in Y. 
lipolytica through metabolic engineering. Dulermo and Nicaud were able to increase lipid 
                                                             
1 Portions of this chapter were reprinted with permission from “Engineering Rhodosporidium toruloides for 
increased lipid production” in the journal Biotechnology and Bioengineering, 2015, by Zhang S, Skerker JM, Rutter 
CD, Maurer MJ, Arkin AP, Rao CV. This article is protected by copyright. All rights reserved. 
22 
 
production two-fold by over-expressing glycerol-3-P dehydrogenase (GPD1) and deleting a 
second isoform of glycerol-3-P dehydrogenase (GUT2) in a strain deficient in beta-oxidation 
(Δpox1-6) (Beopoulos et al., 2008; Dulermo and Nicaud, 2011). Tai and Stephanopoulos 
employed a "push-pull" strategy by over-expressing the native acetyl-CoA carboxylase (ACC1) 
and diacylglycerol acyltransferase (DGA1) enzymes, which increased lipid production five-fold 
(Tai and Stephanopoulos, 2013). In a follow-up study, Qiao and co-workers were able to further 
increase lipid production an additional five-fold by over-expressing delta-9 stearoyl-CoA 
desaturase (SCD) in addition to ACC1 and DGA1 (Qiao et al., 2015). In a separate design, 
Blazeck and co-workers over-expressed the native DGA1 gene in a strain of Y. lipolytica where 
two genes, PEX10 and MFE1, involved in fatty acid catabolism were deleted, resulting in a 
fifteen-fold improvement in lipid production (Blazeck et al., 2014b). They were able to further 
increase lipid production almost nearly four-fold by identifying optimal fermentation conditions.  
In this work, we investigated lipid production and metabolic engineering in 
Rhodosporidium toruloides, a red basidiomycetous yeast. This oleaginous yeast natively 
produces lipids at high titers during growth on glucose, far exceeding what wild-type Y. 
lipolytica is able to produce (Beopoulos et al., 2009; Li et al., 2007). In addition, it can natively 
utilize a wide variety of carbohydrates derived from plant biomass, including xylose and 
cellobiose, unlike Y. lipolytica (Bommareddy et al., 2015; Lane et al., 2014). We characterized 
two strains of R. toruloides, IFO0880 and IFO0559. Both were found to produce greater than 5 
g/L of lipids during growth on glucose in shake flask cultures. We further engineered both strains 
by adapting the “push-pull” strategy of Tai and Stephanopoulos, and were able to produce over 
15 g/L of lipid in IFO0880 and 10 g/L of lipid in IFO559, again in shake flask culture. In 
addition, we found that sugar utilization rates were increased in both engineered strains. 
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2.2 Material and methods 
Strains, media, and growth conditions. Table 2.1 lists all the strains used in this study. 
YPD medium (yeast extract 10 g/L, peptone 20 g/L and glucose 20 g/L) was used for routine 
growth of R. toruloides. Low-nitrogen media (70 g/L glucose or 70 g/L xylose, 0.75 g/L yeast 
extract, 1.7 g/L yeast nitrogen base without amino acids and ammonium sulfate, and 0.1 g/L 
(NH4)2SO4, pH 5.6, C:N = 339) was used to induce lipid production in R. toruloides IFO0880.  
KH2PO4 (1 g/L) and MgSO4.7H2O (1.5 g/L) were used instead of yeast nitrogen base when 
inducing lipid production in R. toruloides IFO0559. MG/L medium (10 g/L Luria-Bertani base 
(Miller), 5 g mannitol, 1 g/L L-glutamic acid, 0.25 g/L KH2PO4, 0.1 g/L NaCl, 0.1 g/L 
MgSO4.7H2O and 1 µg/L biotin, pH 7.0) was used to grow Agrobacterium tumefaciens (Chilton 
et al., 1974). Induction medium consisted of AB salts, 40 mM 2-(N-morpholino)ethanesulfonic 
acid (pH 5.3), 10 mM glucose, 0.5% (w/v) glycerol and 100 µM acetosyringone (Winans et al., 
1988). AB salts were prepared as a 20X stock (20 g/L NH4Cl, 6 g/L MgSO4.7H2O, 3 g/L KCl, 2 
g/L CaCl2.2H2O, 0.05 g/L FeSO4.7H2O, pH 7.1). Antibiotics were used at the following 
concentrations: kanamycin, 40 µg/mL; nourseothricin, 100 µg/mL (liquid) and 200 µg/mL 
(solid); and cefotaxime, 300 μg/ml. 
Stationary phase R. toruloides seed cultures were obtained by inoculating single colonies 
from a YPD agar plate into 2 mL YPD liquid medium. For lipid production, the seed cultures 
were then used to inoculate 25 mL low-nitrogen media with a starting OD of 1, in a 125 mL 
shake flask (Pyrex), and grown at 30°C and 250 rpm. Growth curves were performed in 
duplicate. 
Plasmid construction. All plasmids used in this study are listed in Table 2.1. All primers 
used in this study are listed in Table 2.3. The ACC1 and DGA1 over-expression plasmid for R. 
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toruloides IFO0559, named pGI2-559-ACC1-DGA1, was constructed in two parts. First, the 
ligase chain reaction (LCR) (de Kok et al., 2014) was used to clone the GAPDH promoter fused 
to the ACC1 gene and terminator into the plasmid pUC19. Briefly, the GAPDH promoter was 
PCR amplified from the plasmid pRH2031 using the primers SZ686F and SZ687R. The ACC1 
gene was PCR amplified from IFO0559 genomic DNA as two fragments, using primers SZ688F 
and SZ689R for the upstream fragment and primers SZ690F and SZ691R for the downstream 
fragment. The plasmid backbone of pUC19 was amplified using the primers SZ684F and 
SZ685R. The four fragments were then ligated using the bridge primers 
SZ692/SZ693/SZ694/SZ695, yielding the plasmid pUC19-PGAPDH-ACC1. Next, LCR was used 
to clone the ACL promoter fused to DGA1 gene and terminator into the plasmid pUC19. The 
ACL promoter and DGA1 gene plus terminator were PCR amplified from IFO0559 genomic 
DNA using the primer pairs SZ675F/SZ676R and SZ677F/SZ678R, respectively. The plasmid 
backbone of pUC19 was again amplified, this time using the primers SZ432F and SZ433R. The 
fragments were ligated using LCR with the bridge primers SZ679/SZ680/SZ681, yielding the 
plasmid pUC19-PACL-DGA1. Next, the PGAPDH-ACC1 fragment was digested from 
pUC19-PGAPDH-ACC1 with AvrII and EcoRI. The fragment PACL-DGA1 was PCR amplified 
from pUC19-PACL-DGA1 with primer SZ699F and SZ700R and digested with EcoRI and PacI. 
The PGAPDH-ACC1 and PACL-DGA1 fragments were then cloned into the plasmid pGI2 using the 
AvrII and PacI restriction sites, yielding the plasmid pGI2-559-ACC1-DGA1. 
The ACC1 overexpression plasmid pGI2-880-ACC1 for R. toruloides IFO0880 was 
constructed as follows. First, the GAPDH promoter fused to the ACC1 gene and terminator were 
cloned into pUC19. The GAPDH promoter was PCR amplified from IFO0880 genomic DNA 
using the primers SZ805F and SZ806R. The ACC1 gene and terminator were PCR amplified 
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from genomic DNA using the primer pairs SZ807F/SZ808R (upstream) and SZ809F/SZ810R 
(downstream). The pUC19 plasmid backbone was PCR amplified using the primers SZ825R and 
SZ830F. The four DNA fragments were then ligated together by LCR using the bridge primers 
SZ818, SZ819, SZ820 and SZ831, yielding the plasmid pUC19-880-ACC1. The PGAPDH-ACC1 
DNA fragment was then subcloned into pGI2 using the AvrII and BamHI restriction sites, 
yielding the plasmid pGI2-880-ACC1. The DGA1 overexpression plasmid pGI2-880-DGA1 for R. 
toruloides IFO0880 was cloned as follows. First, the native ACL promoter and DGA1 gene and 
terminator were cloned into pUC19. The ACL promoter was PCR amplified from genomic DNA 
using the primers SZ811F and SZ812R. The DGA1 gene was PCR amplified from genomic DNA 
using the primers SZ813F and SZ814R. The pUC19 plasmid backbone was PCR amplified using 
the primers SZ832F and SZ824R. The three DNA fragments were then ligated together by LCR 
using the bridge primers SZ833, SZ822 and SZ823. The PACL-DGA1 fragment was then 
subcloned into the pGI2 using the BamHI and PacI restriction sites, yielding the plasmid 
pGI2-880-DGA1. The ACC1 and DGA1 overexpression plasmid pGI2-880-ACC1-DGA1 for R. 
toruloides IFO0880 was constructed by subcloning the PGAPDH-ACC1 and PACL-DGA1 DNA 
fragments into pGI2 using the AvrII and PacI restriction sites. 
Transcription fusions to the green fluorescent protein (GFP) were constructed using 
pRH2031 (gift of Temasek Life Sciences Laboratory) as the template (Liu et al., 2013). This 
binary plasmid contains the gene for enhanced GFP codon optimized for R. toruloides under the 
GAPDH promoter for IFO0880. The ACL transcriptional fusion was built by first PCR 
amplifying the ACL promoter using the primers SZ838F and SZ839R using IFO0880 genomic 
DNA as the template. The plasmid pPH2031 was then digested with the restriction enzymes SpeI 
and BamHI and the equivalently digested ACL promoter was then ligated into the same sites, 
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yielding the plasmid pRH2032.  
Agrobacterium tumefaciens mediated transformation (ATMT). pGI2-derived binary 
plasmids were first electroporated into Agrobacterium tumefaciens EHA105 (Abbott et al., 2013; 
Hood et al., 1993). Briefly, A. tumefaciens was subcultured in 50 mL from an overnight seed 
culture until OD reached around 0.5. The culture was first washed with ice cold 1 mM 
4-(2-hydroxyethyl)-1-piperazineethanesulfonic acid (HEPES), pH 7.0, and then washed with 1 
mM HEPES, pH 7.0, 10% glycerol, before finally resuspending in 0.5 mL of ice cold 1 mM 
HEPES, pH 7.0, 10% glycerol. 1 µL of plasmid DNA (50ng - 1 µg) was electroporated using a 
Gene Pulser Xcell (Bio-Rad) with 2.5 kV electrical pulse (field strength of 12.5 kV/cm) and 
recovered in 1 mL MG/L medium at 30°C for 2 hours and then plated onto kanamycin LB plates. 
Colonies formed after 2 days growth at 30°C. 
A. tumefaciens EHA105 strain harboring the binary plasmid was then cultured in 1 mL 
MG/L medium with kanamycin until OD reached approximately 1.0. The cells were then 
pelleted and resuspended in 1 mL induction medium for 7 hours in 30°C. R. toruloides was 
cultured in YPD medium to mid-exponential phase. The cells were then diluted to OD 
approximately 0.5 and mixed with induced A. tumefaciens cells in equal volume to a total 
volume of 1 mL. The mixture was then vacuum filtered using a 0.45 µm filter membrane 
(Millipore). The filter was then placed on an induction medium plate, and incubated at room 
temperature for 2 days. The cells on the membrane were then resuspended with YPD medium 
and plated onto a YPD plate supplemented with nourseothricin and cefotaxime, where the latter 
was used to kill the A. tumefaciens cells. Colonies appeared after 2 days, and were subsequently 
restreaked on YPD plates containing nourseothricin to isolate individual clones. 
Analytical methods. Glucose and xylose concentrations were measured using a 
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Shimadzu high-performance liquid chromatography (HPLC) system equipped with a RID-10A 
refractive index detector and an Aminex HPX-87H carbohydrate analysis column. The column 
was maintained at 65°C and run with 5 mM sulfuric acid at a flow rate of 0.6 ml/min. A cation H 
micro-guard cartridge (Bio-Rad) was also kept at 65°C. Cell growth was measured by the 
absorbance at 600 nm.  
Lipid weight was determined as follows. A 1 mL liquid culture was harvested and 
immediately frozen at -80°C and freeze-dried in Labconco FreeZone 6 freeze dryer. 1 mL of 
chloroform/methanol (2:1 volumetric) (Folch et al., 1957) was added to the dried sample, and the 
mixture was then homogenized three times at 5 m/s for 30 seconds each, using a FastPrep-24 
homogenizer. The samples were then mixed with 0.2 ml water and vortexed for 15 seconds. The 
organic layer was removed using a Hamilton syringe with a long needle. The organic layer was 
washed with 0.1 mL 0.1% (w/v) NaCl water solution, extracted again, and dried in a hood at 
room temperature overnight in a pre-weighed tube. The tube was further dried in an 80°C oven 
for one hour and then weighed to determine lipid content.  Each lipid measurement was 
performed in quadruplet, with two biological replicates and two technical replicates for lipid 
extraction.  
Dry cell weight was determined as follows. A 2 mL liquid culture was vacuum filtered for 
thirty minutes using a pre-weighed 0.45 µm cellulose membrane (Millipore) and then washed 
with water. The filter membranes were dried overnight at room temperature and weighed. Dry 
cell weight measurements were performed in triplicates. The filter membranes were also dried 
for three days to determine whether overnight incubation was sufficient. Because no weight 
differences were observed, overnight incubation was deemed sufficient. Note that we were 
unable to lyophilize the cells due to their buoyancy: many strains are less dense than water and 
28 
 
float on the surface of the media due to their high lipid production. As a consequence, we were 
unable to use centrifugation to wash the cells: direct lyophilization of the culture would 
over-estimate the dry cell weight due to the presence of salts and other compounds within the 
media. 
Lipid composition was determined by thin-layer chromatography (TLC). Extracted lipids 
were resuspended in 0.2 mL hexane, and 2 µl were spotted onto a TLC plate (Millipore, Silica 
gel 60 F254). Standards contained glyceryl trioleate 50 µg/µL, 1,3-diolein 50 µg/µL, 
1,2-dioleoyl-rac-glycerol 50 µg/µL, monoolein and oleic acid 100 µg/µL. 1 µl standards were 
spotted onto the plate. Plates were placed vertically in a closed chamber with the bottom 
touching in mobile phase (hexanes/diethyl ether/acetic acid 70:30:1 volumetric). After 45 
minutes, plates were taken out and heated briefly to let dry. Next, lipids and fatty acids were 
stained in a closed chamber by iodine vapor for 20 minutes. 
Fatty acid composition was determined by gas chromatography-mass spectrometry 
(GC-MS). Fatty acid methyl esters were derivatized by a method adapted from Lepage and Roy 
(Lepage and Roy, 1986). Briefly, extracted lipids were first resuspended in 0.5 mL hexane, then 1 
mL methylation agent (methanol/acetyl chloride 20:1 volumetric) was added, followed by 2.5 µl 
of internal standard (tridecanoic acid 25 mg/mL).  The samples were incubated with occasional 
mixing in boiling water for 15 minutes in glass tubes with screw caps. After cooling down to 
room temperature, 0.5 mL water was added to each sample and then vortexed. After phase 
separation, 0.2 mL of the organic phase was analyzed using a Shimadzu GCMS-QP2010 Plus gas 
chromatograph-mass spectrometer. Samples were run through an Agilent J&W DB-5MS column 
(30 m X 0.250 mm X 0.25 µm) with helium as the carrier gas. The oven temperature started at 
50°C, then increased linearly to 250°C at a rate of 10°C per minute and finally held at 250°C for 
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10 minutes. Fatty acid methyl esters were quantified by peak area. Samples were collected and 
analyzed from four technical replicates. 
Quantitative PCR. Total mRNA was prepared using Qiagen’s RNeasy Mini kit. Cells 
were first mechanically disrupted using acid-washed glass beads (425-600 μm) six times in a 
FastPrep-24 homogenizer with 6 m/s beating for 20 seconds. Total mRNA (2 µg) was then 
treated with Turbo DNase (Ambion) to remove genomic DNA. cDNA was synthesized from 
mRNA using Qiagen’s QuantiTect Reverse Transcription kit. The RT-PCR reaction was 
performed using Qiagen’s QuantiTect SYBR mix with 0.5 µl of template at a total volume of 20 
µl sealed by liquid wax (BIO-RAD Chill-out) in an MJ Mini thermocycler (BIO-RAD).  
Primers were designed using Primer3Plus and are listed in Table 2.3. The actin gene (ACT, 
RHTO_03560) was used as the reference gene for internal control. Standard curves were 
generated using serial dilutions of genomic DNA as the template. All data points were collected 
in triplicate. 
Fluorescence measurements. Both pRH2031 and pRH2032 (listed in Table 2.1) were 
transformed into IFO0880 by ATMT and integrants selected with hygromycin B at a 
concentration of 150 μg/ml. Different colonies were picked and confirmed to have the insert 
T-DNA by PCR. For fluorescence measurements, cultures were inoculated from saturated YPD 
culture into low-nitrogen medium. After 48 hours of growth, 150 μl cultures were aliquoted into 
a microplate and the fluorescence was measured using a Tecan Safire2 plate reader. The 
emission/excitation wavelengths were 490/510 nm. Relative fluorescence was calculated by 
normalization to optical density at 600 nm.  Samples were analyzed in biological triplicate for 
each integrant. 
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2.3 Results 
2.3.1 Initial characterization of R. toruloides.  
Numerous studies have shown that R. toruloides is capable of natively producing lipids at 
high titers (Li et al., 2007; Wiebe et al., 2012; Zhao et al., 2011). We tested two strains, IFO0880 
and IFO0559, for their ability to produce lipids during growth on glucose in low-nitrogen media. 
These two strains were chosen because they are both haploid strains of opposite mating type and 
the subject of several previous studies on the R. toruloides life cycle (Banno, 1967; Yamada et al., 
1989).  In addition, a closely related haploid strain (NP11) had previously been characterized in 
a multi-omic study (Zhu et al., 2012). After 240 hours of growth in shake-flask cultures in 
low-nitrogen media with a starting glucose concentration of 70 g/L, the two strains IFO0880 and 
IFO0559 were found to produce 7.7±0.3 g/L and 6.3±0.3 g/L total lipid, respectively. We also 
tested the composition of these lipids and found that they were predominantly in triglyceride 
form as determined by thin-layer chromatography (Figure 2.5). These results demonstrate that R. 
toruloides can natively produce lipids, primarily in triglyceride form, at high titers during growth 
on glucose. 
2.3.2 Genome sequencing of R. toruloides strains IFO0559 and IFO0880.  
Multiple studies have shown that lipid production in Y. lipolytica can be significantly 
increased through metabolic engineering. An open question was whether we could do the same 
in R. toruloides. As the genome sequences were not previously available for the two strains 
IFO0880 and IFO0559, our collaborators Dr. Jeffrey Skersker and Dr. Matthew Maurer at Prof. 
Adam Akin lab sequenced the two strains’ genomes and generated draft genome assemblies and 
annotations. The number of predicted proteins for IFO0559 and IFO0880 is 8,100 and 7,920, 
respectively. As a comparison, the previously sequenced strain R. toruloides NP11 has 8,139 
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predicted proteins. Comparison of the genome sequences for IFO0559 and IFO0880 revealed 
over one million single nucleotide variations (SNPs), consistent with their native differences in 
lipid production. In addition, the genome sequence for IFO0559 was found to be nearly identical 
to NP11 (443 SNPs) and the IFO0880 nearly identical to Rhodotorula glutinis ATCC 204091 
(474 SNPs) (Paul et al., 2014). In fact, ATCC 204091 has more recently been designated as 
Rhodosporidium toruloides, and may actually be IFO0880.  It is difficult to trace the origins of 
these strains due to altered strain designations given by different laboratories and their sourcing 
from different public culture collections.  Our results emphasize the importance of sample 
tracking and verification by genome sequencing when obtaining new strains from culture 
collections. 
 2.3.3 Over-expression of ACC1 and DGA1 in R. toruloides strains.  
Genetic tools in R. toruloides are far less developed than in the paradigm oleaginous 
yeast, Y. lipolytica. Recently, two groups have demonstrated that R. toruloides could be 
transformed using A. tumefaciens (Lin et al., 2014; Liu et al., 2013). We adapted this technology 
to transform the two strains of R. toruloides. Briefly, R. toruloides was incubated with induced A. 
tumefaciens EHA105 harboring the binary plasmid pGI2 (with the genes of interest cloned 
between the left and right T-DNA borders), and plated on selective media. Using this method, we 
were able to efficiently transform both strains of R. toruloides, and routinely obtained 102-104 
transformants per reaction.  In addition, we found that this method could be used to transform Y. 
lipolytica (data not shown) though it is far more labor intensive than traditional methods, such as 
electroporation or lithium acetate transformation (Chen et al., 1997; Wang et al., 2011). 
Having established that we could transform R. toruloides using ATMT, we next sought to 
engineer both strains for increased lipid production. However, in choosing a strategy, we were 
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limited in scope because deleting genes in R. toruloides is still very inefficient in our hands and, 
as a consequence, we focused on designs that solely involved gene over-expression. We choose 
therefore to adapt the "push-pull" strategy of Tai and Stephanopoulos, previously developed for Y. 
lipolytica, as it simply involves over-expressing two native genes: acetyl-CoA carboxylase 
(ACC1) and diacylglycerol acyltransferase (DGA1) (Figure 2.1A).  
To implement this strategy in R. toruloides, we used the glyceraldehyde-3-phosphate 
dehydrogenase (GAPDH) promoter to over-express the native ACC1 gene and the ATP-citrate 
lyase (ACL) promoter to over-express the native DGA1 gene. These promoters were chosen 
because they were found in a previous transcriptome study to be highly active in the related 
strain NP11 (Zhu et al., 2012). The promoters and genes were then cloned into the binary 
plasmid pGI2 as shown in Figure 2.1B and randomly integrated into the chromosome as a single 
construct into R. toruloides using A. tumefaciens mediated transformation, yielding the strains 
RT880-AD and RT559-AD. In addition to using the native genes from each strain, we also 
explored a hybrid design where we over-expressed the genes from strain IFO0559 in strain 
IFO0880, yielding the strain RT880-ADhy.  
As ATMT-mediated integration is random, we tested multiple colonies for lipid 
production. Significant variation in the lipid titers was observed among individual clones 
(Figure 2.6). However, the individual clones themselves exhibited far less variation suggesting 
that the differences among clones were due to random integration and not intrinsic factors. All 
clones had lipid titers at least as great as the wild-type controls (transformed with just the 
antibiotic resistance marker), indicating that the increased lipid titers were most likely due to 
overexpression of ACC1 and DGA1. We choose the highest lipid producer for each clone and 
then confirmed that the ACC1 and DGA1 genes were being over-expressed using quantitative 
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PCR. As shown in Figure 2.2, the ACC1 and DGA1 genes were over-expressed in all three 
strains relative to the wild-type control during the entire growth phase. In general, we observed 
somewhat higher levels of expression for both genes in IFO0880 (at least ten-fold) than in 
IFO0559 (less than ten-fold). These results confirm that GAPDH and ACL promoters can be used 
to over-express genes in R. toruloides though these promoters are more active in IFO0880.  
2.3.4 Total lipid production is increased in R. toruloides when ACC1 and DGA1 are 
over-expressed.  
We next characterized lipid production in our three strains (RT880-AD, RT559-AD, 
RT880-ADhy) during shake-flask growth with glucose or xylose (70 g/L) in low-nitrogen media. 
As shown in Figure 2.3 and tabulated in Table 2.2, the lipid titers were increased in all three 
strains relative to the negative controls (the wild-type strain transformed with the empty pGI2 
plasmid) on glucose. The increases were most pronounced for the strains derived from IFO0880 
(RT880-AD and RT880-ADhy) grown on glucose, where the final lipid titers were 
approximately 15 g/L. Relative to the wild type, lipid titers were increased by 95% in the strain 
RT880-AD and 73% in the strain RT880-ADhy. Lipid yields were increased by 92% in 
RT880-AD and 75% in RT880-ADhy. The increases were far less pronounced for the strain 
derived from IFO0559 (RT559-AD), where the final titers were approximately 9 g/L during 
growth on glucose. This represents a 28% increase in lipid titers and 30% increase in lipid yields. 
These results are somewhat surprising. While one would expect strains derived from IFO0880 to 
have higher titers given its greater native capacity for lipid production, over-expression of the 
IFO0559 genes in IFO0880 yields a greater increase than in the native IFO0559 host. One 
possible explanation is that the GAPDH and ACL promoters are more active in IFO0880 than in 
IFO0559 (Figure 2.2). 
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To determine if the lipid increases were due to increased cell proliferation, we measured 
the number of colony forming units during growth in low-nitrogen media with glucose (Figure 
2.7). For all three engineered strains, we observed less cell proliferation than in the wild type. 
These results demonstrate that the increased lipid titers are not due to increased cell proliferation 
but rather more carbon being directed toward lipid synthesis. These results are consistent with 
our dry cell weight measurements and lipid content calculations (Table 2.2). 
To determine whether the composition of the lipids changed in the engineered strains, we 
used thin-layer chromatography and GC-MS to analyze the extracted lipids (Figures 2.5 and 
2.8). Similar to the wild type, the lipids are predominantly in triglyceride form with small 
amounts in diglyceride from (Figure 2.5). No free fatty acids were observed, except that only 
RT559-N showed negligible amount of free fatty acids. The fatty acid composition of the 
engineered and wild type strains, as determined by fatty acid methyl ester analysis using GC-MS, 
was also found to be similar with oleic acid and palmitic acid predominating (Figure 2.8). 
The increases in lipid titers for all three strains were not as large during growth on xylose: 
titers increased by 34% in the IFO0880-derived strains and no statistically significant increase 
was observed in the IFO0559-derived strains. In addition, xylose utilization is far less efficient 
than glucose utilization, evident with the relatively long times required for complete sugar 
consumption. Overall, R. toruloides grows less well on xylose than glucose. Similar results have 
been observed by others (Wiebe et al., 2012).  The reasons are not known. 
Collectively, these results demonstrate that over-expression of the ACC1 and DGA1 
genes by ATMT significantly increases lipid production in IFO0880 during growth on glucose 
but only moderately during growth on xylose. Over-expression of these two genes in IFO0559 
resulted in only moderate increases during growth on glucose and negligible increases during 
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growth on xylose. 
2.3.5 Over-expression of ACC1 and DGA1 increases sugar utilization in R. toruloides.  
We next measured the rate of glucose and xylose consumption in our three engineered 
strains. In the two strains derived from IFO0880 (Figures 2.4A and B), glucose consumption 
rates were increased relative to the wild-type control. In particular, after 210 hours of growth, 
both strains consumed all of the glucose whereas the wild type did not. Likely, increased glucose 
utilization is due to increased carbon flux into lipid production. No significant increase in 
glucose consumption was observed with RT559-AD relative to wild type (Figure 2.4C), 
consistent with the relatively poor performance of this strain. Likewise, xylose consumption was 
only moderately increased, with the most pronounced effects observed in RT880-ADhy and 
RT559-AD. 
2.3.6 Variability among strains.  
Significant variability in lipid production was observed between individual 
ATMT-derived clones (Figure 2.6), as discussed above. This variation may be due to random 
integration of the T-DNA, where the specific genomic location or the particular genes disrupted 
may affect transcription of ACC1 and DGA1 directly, or indirectly affect transcription and/or 
lipid production by some unknown secondary effects (Xue et al., 2013). Alternatively, the 
integrated T-DNA may form concatemers, which would increase the gene dosage and 
presumably the level of transcription. As a first step, we tried to use arbitrary PCR to map the 
location of the T-DNA inserts to determine whether genes involved in lipid biosynthesis may 
have been disrupted and/or multiple copies of the T-DNA had been inserted into the genome.  
Our mapping efforts were unsuccessful due to the T-DNA likely forming concatemers or 
inserting into multiple locations (data not shown), which still raised the possibility that the 
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increased lipid titers we observed were due to random insertion and inactivation of unknown 
gene(s) that increase lipid production rather than due to increased expression of ACC1 and DGA1. 
To distinguish between these possibilities, we measured lipid titers in 10 clones of IFO0880 
transformed with T-DNA containing just the antibiotic resistance marker. For all ten of these 
negative-control clones, lipid titers never exceeded 8 g/L (Figure 2.6). As a comparison, the lipid 
titers for nine of the twelve RT880-AD clones, four of the ten RT880-ACC1 (over-expressing 
just ACC1), and nine of nine RT880-DGA1 (over-expressing just DGA1) clones exceeded this 
value (Figure 2.6). Importantly, none of our ATMT-engineered clones had lipid titers less than 
the negative-control clones. These results strongly suggest that the increased lipid titers are due 
to over-expression of the ACC1 and DGA1 genes encoded on the integrated T-DNA cassette and 
that the likelihood for the alternate possibility (gene inactivation) is extremely low.  
We next explored gene expression in different clones of IFO0880-derived strains. We first 
considered variability among strains expressing either ACC1 or DGA1 (Figures 2.9). When we 
compared these two strains, we observed significantly more variability in strains individually 
expressing ACC1 than DGA1. When we compared gene expression in these two strains (Figure 
2.9A), we observed more variability in ACC1 gene expression than with DGA1 gene expression. 
Moreover, the relative level of expression is loosely correlated with lipid titers, where increased 
expression leads to more lipid production (Figure 2.9). Consistent with these measurements, we 
found that the GAPDH promoter is more variable across clones than the ACL promoter, as 
determined using transcriptional fusions to the green fluorescent protein (Figure 2.10). Note, the 
GAPDH promoter is significantly stronger than the ACL promoter. As a consequence, it may be 
more sensitive to the integration site or gene dosage. While these results provide one possible 
explanation for the observed variability in strains expressing a single gene, they do not explain it 
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in strains expressing both genes in tandem (Figure 2.9). Here, we do not observe a simple 
correlation between expression levels and lipid titers. Likely, this reflects the need to balance 
flux in the pathway and the general “push-pull” strategy involved in the design.  
2.3.7 Contribution of ACC1 and DGA1 towards lipid production.  
Two genes were over-expressed to improve lipid production in R. toruloides. One 
immediate question concerns how these genes individual contribute to lipid production. Our 
results suggest that the relationship is complex (Figure 2.6). The lipid titers for individual clones 
over-expressing just DGA1 (RT880-DGA1) exhibited far less variability than those 
over-expressing both genes (RT880-AD) or those over-expressing just ACC1 (RT880-ACC1). In 
addition, the average lipid titer among all RT880-DGA1 clones was slightly higher than the 
average titer among all RT880-AD clones (12.8 g/L versus 12.0 g/L). However, we were able to 
isolate a number of RT800-AD clones with lipid titers far greater than could be obtained by any 
of the clones over-expressing just DGA1. Some RT880-AD clones did not produce significantly 
more lipid than the negative control strain, which brought down the overall average. These 
results demonstrate that over-expression of DGA1 yields consistent titer increases whereas 
over-expression of ACC1 yields variable increases, with the latter having a dominant effect. They 
also demonstrate that over-expression of both genes is necessary to maximize lipid production. 
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2.4 Discussion 
R. toruloides is a promising microorganism for the production of lipid-based chemicals 
because it naturally produces lipids at high titers (Ageitos et al., 2011; Evans and Ratledge, 1984; 
Jin et al., 2013). In addition, it can grow on glucose and xylose, the two main sugars in 
lignocellulosic biomass (Bommareddy et al., 2015; Wiebe et al., 2012). In this work, we 
engineered two strains of R. toruloides for increased lipid production by over-expressing 
acetyl-CoA carboxylase and diacylglycerol acyltransferase, the enzymes that catalyze the first and 
last steps in triacylglyceride biosynthesis. Over-expression of these enzymes has been shown to 
increase lipid production in diverse microorganisms (Davis et al., 2000; Feng et al., 2014; 
Kamisaka et al., 2007; Runguphan and Keasling, 2014), most notably Y. lipolytica as recently 
demonstrated by Tai and Stephanopoulos (Tai and Stephanopoulos, 2013). Our best strain, 
RT880-AD, produced 16 g/L of lipid during growth on glucose, representing a two-fold increase 
relative to the wild-type strain IFO0880. Direct comparisons to other studies investigating 
oleaginous yeast, however, are challenging, as our analysis was limited to shake-flask growth 
whereas others characterized their strains in fermenters. Nonetheless, when limiting the 
comparison to shake-flask growth, our best titers are at least two-fold greater than what has been 
previously reported (Blazeck et al., 2014b; Qiao et al., 2015).  
Future work clearly needs to focus on process and media optimization, coupled with the 
use of fermenters for high-density cell cultures (Li et al., 2007). In the present study, only 
shake-flask growth was explored without considering different media formulations or initial cell 
concentrations. Others have shown that optimizing these factors can significantly improve the 
numerous performance metrics for the fermentation (Blazeck et al., 2014b; Qiao et al., 2015; Tai 
and Stephanopoulos, 2013).  
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The reason that we explored two strains of R. toruloides was to account for potential 
differences among the two in terms of their native capacity to produce lipids. Little is known in 
general about genetic and phenotypic diversity in this species of yeast, so we decided against 
choosing one strain at the outset of this study. In addition, genome sequencing revealed 
numerous single nucleotide variations, suggesting that the two strains would perform differently, 
as indeed our data show. Strains derived from IFO0880 consistently outperformed those from 
IFO0559, even when we expressed IFO0559 genes in IFO0880. The origin of these differences is 
not presently known, though they nonetheless demonstrate that IFO0880 is a better host for 
future metabolic engineering than IFO0559. 
The genetic toolbox in R. toruloides is still limited. Facile transformation methods are not 
available, and currently the most efficient method involves A. tumefaciens mediated 
transformation. While this method can be used to over-express genes, we are still limited in our 
ability to genetically engineer R. toruloides.  Recently, deletion of the KU70 gene was reported 
to improve the efficiency of targeted deletion, but even in this strain background it varied 
depending on the particular locus (Koh et al., 2014).  However, with these basic tools for 
over-expression and targeted deletion, it should be possible to further optimize our 
over-expression strain, and continue to increase lipid yields and productivity.  Clearly, more 
advanced genetic tools in R. toruloides need to be developed if we are to realize the full potential 
of this microorganism as a platform for producing lipid-based chemicals. 
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2.5 Tables and figures 
Table 2.1 List of plasmids and strains 
 
Plasmids Genotypes/features* Source/references 
pGI2 KanR for bacteria, NatR for yeast, binary plasmid (Abbott et al., 2013) 
pRH2031 PGAPDH(880) –eGFP, SpecR for bacteria, HygR for yeast (Liu et al., 2013) 
pRH2032 PACL(880) –eGFP, SpecR for bacteria, HygR for yeast This study 
pGI2-559-ACC1-DGA1 pGI2-PGAPDH(880) -ACC1(559)-TACC1(559)-PACL(559)-DGA1(559) –TDGA1(559)   This study 
pGI2-880-ACC1 pGI2-PGAPDH(880)-ACC1(880)-TACC1(880) This study 
pGI2-880-DGA1 pGI2-PACL(880)-DGA1(880)-TDGA1(880) This study 
pGI2-880-ACC1-DGA1 pGI2-PGAPDH (880)-ACC1(880)-TACC1(880)-PACL(880) -DGA1(880)-TDGA1(880) This study 
Strains   
IFO0880 Rhodosporidium toruloides strain IFO0880, mating type A2 NBRC culture collection  
IFO0559 Rhodosporidium toruloides strain IFO0559, mating type A1 NBRC culture collection 
RT880-ADhy IFO0880/ pGI2-559-ACC1-DGA1 This study 
RT880-ACC1 IFO0880/ pGI2-880-ACC1 This study 
RT880-DGA1 IFO0880/ pGI2-880-DGA1 This study 
RT880-AD IFO0880/ pGI2-880-ACC1-DGA1 This study 
RT880-N IFO0880/ pGI2 This study 
RT559-AD IFO0559/ pGI2-559-ACC1-DGA1 This study 
RT559-N IFO0559/ pGI2 This study 
* Subscripted numbers denote gene origin. 
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Table 2.2 Results for engineered strain versus wild type control.  
Strain Carbon source 
Total lipid 
(g/L) 
Dry cell 
weight 
(g/L) 
Lipid content 
(%) 
Lipid 
production 
rate (g/L h) 
Specific 
productivity 
(g/gDCW h) 
Lipid yield   
(g/g sugar) 
Harvest 
Time 
(h) 
RT880-N 
Glucose 8.4±1.4 26.8±1.8 31.3±5.7 0.04±0.01 0.14±0.03 0.12±0.02 217 
Xylose 7.1±1.5 20.1±0.8 35.5±7.5 0.02±0.01 0.09±0.02 0.10±0.02 385 
RT880-ADhy 
Glucose 14.5±0.5 26.0±0.5 55.9±2.3 0.08±0.01 0.29±0.01 0.21±0.01 192 
Xylose 9.5±0.8 20.1±0.1 47.2±4.0 0.03±0.01 0.15±0.01 0.14±0.01 310 
RT880-AD 
Glucose 16.4±1.1 26.8±1.5 61.1±5.3 0.08±0.01 0.28±0.02 0.23±0.02 217 
Xylose 9.5±1.3 21.9±3.3 43.4±8.8 0.03±0.01 0.11±0.02 0.14±0.02 385 
RT559-N 
Glucose 7.1±0.7 16.6±0.5 42.9±4.5 0.03±0.01 0.15±0.02 0.10±0.01 289 
Xylose 6.5±1.2 11.7±0.6 55.6±10.3 0.02±0.01 0.18±0.03 0.10±0.02 313 
RT559-AD 
Glucose 9.1±0.5 15.6±0.1 58.4±3.0 0.03±0.01 0.20±0.01 0.13±0.01 289 
Xylose 7.5±0.7 13.1±0.4 57.0±5.4 0.02±0.01 0.18±0.02 0.11±0.01 313 
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Table 2.3 Primers used in this study 
Primer Sequence Note 
Cloning 
SZ686F  CTGCAGAACTACGCCCTCTC  IFO0880_PGAPDH  
SZ687R  TGTGAGTGATCTGGTGTTGTTCTGAGCG  IFO0880_PGAPDH  
SZ688F  ATGCCGTGCGTCGCCTCCCTTTCG  IFO0559_ACC1_U  
SZ689R  GGGGAAGTGTCGGAGGACGGTACCG  IFO0559_ACC1_U 
SZ690F  GACTCGAACAAGGGCAAGCTCCAG  IFO0559_ACC1_D  
SZ691R  GTTAGTGGGCAGCATGTGTGAGA  IFO0559_ACC1_D  
SZ684R  CCTAGGACTGGCCGTCGTTTTACAAC  pUC19 backbone  
SZ685F  GAATTCCATGGTCATAGCTGTTTCCTGTG  pUC19 backbone  
SZ692F  CACGACGTTGTAAAACGACGGCCAGTCCTAGGCTGCAGAACTACGCCCTCTCACACCCAA  bridge  
SZ693F  CCCGCTCAGAACAACACCAGATCACTCACAATGCCGTGCGTCGCCTCCCTTTC  bridge  
SZ694F  GCTCGGTACCGTCCTCCGACACTTCCCCGACTCGAACAAGGGCAAGCTCCAGCAGCA  bridge  
SZ695F  
CGCCTCTCTCACACATGCTGCCCACTAACGAATTCCATGGTCATAGCTGTTTCCTGTGTGAAATTGTT
ATCCGCT  
bridge  
SZ675F  GTGCAGTCGAGGGGGCGCTT  IFO0559_PACL 
SZ676R  TGCTGCTGCTTGAACGTCGG  IFO0559_PACL  
SZ677F  ATGGGCCAGCAGGCGACGCC  IFO0559_DGA1  
SZ678R  AGCTTCGGCGAGGAGGAGGG  IFO0559_DGA1  
SZ432F  CACAGATGCGTAAGGAGAAAATAC  pUC19 backbone  
SZ433R  TATTTCACACCGCATATGGTGCACTC  pUC19 backbone  
SZ679F  TACTGAGAGTGCACCATATGCGGTGTGAAATAGTGCAGTCGAGGGGGCGCTTGTATCTGT  bridge  
SZ680F  CCCAACCACCGACGTTCAAGCAGCAGCAATGGGCCAGCAGGCGACGCCC  bridge  
SZ681F  GGCTTCCCTCCTCCTCGCCGAAGCTCACAGATGCGTAAGGAGAAAATACCGCATCAGGCG  bridge  
SZ699F  ATGAATTCGTGCAGTCGAGGGGGCGCTT  PACL-DGA1  
SZ700R  CATTAATTAAAGCTTCGGCGAGGAGGAGGG  PACL-DGA1  
SZ805F  CTGCAGAACTACGCCCTCTC  IFO0880_PGAPDH  
SZ806R  TGTGAGTGATCTGGTGTTGTTCTG  IFO0880_PGAPDH  
SZ807F  ATGCCGTGCGTCGCCTCCCTTTCG  IFO0880_ACC1_U  
SZ808R  AATGTCGAGGAGGGCGAGGACGA  IFO0880_ACC1_U  
SZ809F  GTCAAGGACTCGGACTCGGTCCCG  IFO0880_ACC1_D  
SZ810R  GCCATTTCGCCGCACGTGACGCTG  IFO0880_ACC1_D  
SZ811F  GGATCCGGGTTGCGAGGTGGGTAACGGAG IFO0880_PACL 
SZ812R  TGCTGCTGCGTTTCCTGGTACGTCGG  IFO0880_PACL  
SZ813F  ATGGGCCAGCAGGCGACGCTCG  IFO0880_DGA1  
SZ814R  GCGAGGAGGAGGAAAGCCGCGTG IFO0880_DGA1  
SZ825R  CCTAGGTATTTCACACCGCATATGGT  pUC19 backbone 
SZ830F  GGATCCTCTAGAGTCGACCTG  pUC19 backbone 
SZ818  
GCAGATTGTACTGAGAGTGCACCATATGCGGTGTGAAATACCTAGGCTGCAGAACTACGCCCTCTCA
CA  
bridge 
SZ819  TACCCGCTCAGAACAACACCAGATCACTCACAATGCCGTGCGTCGCCTCCCTTTCGC  bridge 
SZ820  GCTCGTCCTCGCCCTCCTCGACATTGTCAAGGACTCGGACTCGGTCCCGC  bridge 
SZ831  CAGCGTCACGTGCGGCGAAATGGCGGATCCTCTAGAGTCGACCTGCAGGCATGCAAG  bridge 
SZ811F  GGATCCGGGTTGCGAGGTGGGTAACGGAG IFO0880_PACL 
SZ812R  TGCTGCTGCGTTTCCTGGTACGTCGG  IFO0880_PACL  
SZ813F  ATGGGCCAGCAGGCGACGCTCG  IFO0880_DGA1  
SZ814R  GCGAGGAGGAGGAAAGCCGCGTG IFO0880_DGA1  
SZ832R  TATTTCACACCGCATATGGTG  pUC19 backbone 
SZ824F  TTAATTAACACAGATGCGTAAGGAGAAAATAC  pUC19 backbone 
SZ833  AGATTGTACTGAGAGTGCACCATATGCGGTGTGAAATAGGATCCGGGTTGCGAGGTGGGTAACG  bridge 
SZ822  CCGACGTACCAGGAAACGCAGCAGCAATGGGCCAGCAGGCGACGCTCG  bridge 
SZ823  CACGCGGCTTTCCTCCTCCTCGCTTAATTAACACAGATGCGTAAGGAGAAAATACCGCATCAGGC  bridge 
SZ838F  GAACTAGTGGGTTGCGAGGTGGGTAACGGAGG  PACL 
SZ839R  CCGGATCCGCCATTGCTGCTGCGTTTCCTGGTACG  PACL  
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Table 2.3 (cont.) 
RT-PCR 
SZ788F  CACGAACGTCTGGGGTTACT  IFO0559_ACC1  
SZ789R  GTGATCGTGTTCTGCTCGAA  IFO0559_ACC1  
SZ786F  CCTCACCTGGGTCTTTTTCA  IFO0559_DGA1  
SZ787R  GGGTGGTAGCCAAAGACGTA  IFO0559_DGA1 
SZ790F  GCGACATCAAGGAGAAGCTC  IFO0559_ACT 
SZ791R  GATGTCGAGATCGCACTTCA  IFO0559_ACT 
SZ906F  AGGCGATCTTCGACTTCAAC  IFO0880_ACC1 
SZ907R  CGTTCGGGACGATGTAGAC  IFO0880_ACC1 
SZ908F  AGAGTCGGATATGGGTCTGG  IFO0880_DGA1 
SZ909R  AAGTTGCTTTGGAGGGTGAG  IFO0880_DGA1 
SZ861F  CCTCTACGGCAACATTGTCA  IFO0880_ACT 
SZ862R  TTCGAGATCCACATCTGCTG  IFO0880_ACT 
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Figure 2.1 Diagram of metabolic pathway and target constructs. A) Metabolic pathway for lipid 
synthesis with glucose as the carbon source in Rhodosporidium toruloides. Abbreviations are: 
ACC, acetyl-CoA carboxylase; DGA, diacylglyceride acyltransferase; and FAS, fatty acid 
synthase. Gene names in red indicate the over-expression targets in this study. B) Schematic 
representation of binary plasmid used to transform R. toruloides. ACC1 and its native terminator 
was fused to GAPDH promoter, DGA1 and its native terminator was fused to ACL promoter. The 
double over-expression cassette and nourseothricin resistance cassette were cloned between the 
(T-DNA) left and right borders (LB and RB) to enable Agrobacterium tumefaciens mediated 
transformation. 
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Figure 2.2 Relative mRNA expression of ACC1 (A and B) and DGA1 (C and D) for engineered 
strain versus wild type control during growth in low nitrogen medium with glucose. Color codes 
are RT880-N (purple), RT880-ADhy (blue), RT880-AD (red), RT559-N (orange) and RT559-AD 
(green). The expression levels were quantified by quantitative PCR using the actin gene as the 
internal control.  Standard deviations of three biological replicates are shown for each strain.  
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Figure 2.3 Total lipid titer for engineered strain versus wild type control. RT880-N (purple), 
RT880-ADhy (blue), RT880-AD (red), RT559-N (orange) and RT559-AD (green) strains were 
cultured in low-nitrogen media with glucose (70g/L) or xylose (70g/L) as the sole carbon source. 
Harvest times were tabulated in Table 2.  Mean and standard deviations are reported for each 
strain, based on four replicates (2 biological replicates and 2 technical lipid extraction replicates). 
*P < 0.05; **P < 0.01; **P < 0.001; ns, P > 0.05. 
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Figure 2.4 Growth curves of different strains on glucose (70 g/L) (A,B,C) or xylose (70 g/L) 
(D,E,F). A,D) RT880-ADhy versus RT880-N. B,E) RT880-AD versus RT880-N. C,F) 
RT559-AD versus RT559-N. Squares and triangles were used to denote glucose and xylose, 
respectively. Circles were used to denote the optical density (OD600). Solid symbols were used to 
denote the engineered strains and open ones for the negative control strains. For each plot, sugar 
concentration and OD600 values are plotted on the left and right Y-axis, respectively. 
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Figure 2.5 Lipid composition as determined by thin-layer chromatography. Lane 1 and 5 
were standards (TAG: glyceryl trioleate 50 µg, DAG: 1,3-diolein 50 µg and 
1,2-dioleoyl-rac-glycerol 50 µg, MAG: monoolein, and FFA: oleic acid 100 µg). Extracted 
lipids were from RT880-ADhy (lane 2), RT559-N (lane 3), RT559-AD (lane 4), RT880-N 
(lane 6), RT880-ACC1 (lane 7), RT880-DGA1 (lane 8), and RT880-AD (lane 9). 
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Figure 2.6 Total lipid in low-nitrogen medium with glucose as the sole carbon source. Numbers 
under x-axis represent different ATMT-derived clones for the respective engineered strains 
(ADhy, AD, ACC1, and DGA1). RT880-N represents clones derived from IFO0880 transformed 
with a negative control plasmid, which contains only the nourseothricin drug resistance marker.  
The thin red-line denotes the average lipid titer for the wild-type control strains. Similar 
variability was also observed with strains derived from IFO559 (data not shown). 
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Figure 2.7 Number of colony forming units (CFU) per mL as a function of time for A) RT880-N, 
RT880-ADhy and RT880-AD and B) RT559-N and RT559-AD during growth in low nitrogen 
medium with glucose. Cultures from different time points were diluted in PBS and plated onto 
YPD agar plates in triplicates. After 2 days, colonies were counted. 
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Figure 2.8 Fatty acid composition measured by GC-MS. Engineered strains RT880-N, 
RT880-ADhy, RT880-AD, RT559-N, and RT559-AD were grown in low-nitrogen medium with 
either glucose (A) or xylose (B) as the sole carbon source. C14: myristic acid; C16: palmitic acid; 
C18: stearic acid; C18:1: oleic acid; C18:2: linoleic acid. 
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Figure 2.9 Gene expression and lipid titer variation among different clones of engineered strains. 
A) Relative mRNA expression of ACC1 and DGA1 from different ATMT-derived colonies for 
strains RT880-ACC1, RT880-DGA1, RT880-AD and RT880-N quantified by q-PCR. B) Total 
lipid titer of these strains harvested at hour 192.  
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Figure 2.10 Fluorescence measurements of promoter strength. The green fluorescent protein 
(eGFP) protein was expressed from the GAPDH or ACL promoter in IFO0880. Relative 
fluorescence values were normalized by OD600. Different ATMT-derived clones are indicated by 
numbers 1 through 6. The symbol N denotes IFO0880 lacking the eGFP expression cassette. 
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Chapter 3: Exploring more genetic strategies to improve lipid production in R. 
toruloides 
3.1 Introduction 
Oleaginous yeasts is a category of highly promising microorganisms for de novo 
production of lipid based molecules, as it is able to accumulate large quantities of 
triacylglyceride (TAG) in the lipid body inside the cell. The TAG can be transesterified into fatty 
acid methyl esters (FAME) for biodiesel.  
In order to improve lipid production in oleaginous yeast, various metabolic engineering 
strategies have been explored in a few oleaginous yeasts, mainly in Yarrowia lipolytica. Tai and 
Stephanopoulos employed a push and pull strategy in Y. lipolytica by over-expressing ACC1 and 
DGA1(Tai and Stephanopoulos, 2013), and later same group added another pull by 
over-expressing SCD and achieved 3.5-5 fold increase in lipid productivity (Qiao et al., 2015). 
Blazeck at al combined over-expressing DGA1 and deleting MFE1 and PEX10, which yielded 6 
g/L lipid and 16.8 % lipid content in a small test tube scale, and achieved 25.3 g/L lipid and 88% 
lipid content in bioreactors in Y. lipolytica (Blazeck et al., 2014a).  Dulermo and Nicaud 
diverted more carbon for glycerol backbone for lipid production by over-expressing glycerol-3-P 
dehydrogenase (GPD1) and deleting glycerol-3-P dehydrogenase (GUT2) and increased lipid 
content 2-fold. Zhang et al approached lipid production by providing more reducing agent 
NAPDH by over-expressing malic enzyme (ME) and got 2.5 fold increase lipid accumulation in 
Mucor circinelloides (Zhang et al., 2007).   
Rhodosporidium toruloides is one of the highest lipid producing oleaginous yeast that has 
been reported to store up to 70% its dry cell mass as lipid (Ratledge and Wynn, 2002). This host 
has been demonstrated in high cell density bioreactors to produce lipid from a variety of 
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feedstock, such as glucose, xylose, arabinose, sucrose, glycerol etc. (Bommareddy et al., 2015; 
Zhao et al., 2011). Yet metabolic engineering of R. toruloides only emerges in recent years due to 
limited genetic tools available. We have previously sequenced two wildtype R. toruloides strain 
IFO0880 and IFO0559. We also improved lipid in shake-flask culture by metabolic engineering 
R. toruloides by over-expressing two native enzymes, ACC1 and DGA1, which drives more 
carbon flux into fatty acid synthesis and maturation of TAG. In this study we aim to further 
improved lipid production by exploring more strategies: 1. Providing more cofactor regeneration 
by over-expressing malic enzyme (ME) and pyruvate carboxylase (PYC); 2. Drive more carbon 
to glycerol backbone synthesis by over-expressing glycerol-3-P dehydrogenase (GPD); 3. 
Improving fatty acid maturation by over-expressing stearoyl CoA desaturase (SCD); 4. 
Attempting to eliminate fatty acid degradation pathway by deleting peroxisome structure gene 
PEX10. After testing these hypothesis and combined most beneficial genetic manipulation, our 
final strain, RT880-ADS, which over-expressed ACC1, DGA1 and SCD were able to produce 
lipid 18.6 ± 1.3 g/L from 70 g/L glucose in shake-flask, and 89.4 ± 4.5g/L lipid in fed-batch 
bioreactor with 0.621 ± 0.031 g/L/hour lipid and 0.22 ± 0.01 g/g lipid yield. 
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3.2 Materials and methods 
Strains, media, and growth conditions. Table 3.1 lists all the strains used in this study. 
YPD medium (yeast extract 10 g/L, peptone 20 g/L and glucose 20 g/L) was used for routine 
growth of R. toruloides. Low-nitrogen media (70 g/L glucose or 70 g/L xylose, 0.75 g/L yeast 
extract, 1.7 g/L yeast nitrogen base without amino acids and ammonium sulfate, and 0.1 g/L 
(NH4)2SO4, pH 5.6, C:N = 339) was used to induce lipid production in R. toruloides IFO0880.  
MG/L medium (10 g/L Luria-Bertani base (Miller), 5 g mannitol, 1 g/L L-glutamic acid, 0.25 g/L 
KH2PO4, 0.1 g/L NaCl, 0.1 g/L MgSO4.7H2O and 1 µg/L biotin, pH 7.0) was used to grow 
Agrobacterium tumefaciens (Chilton et al., 1974). Induction medium consisted of AB salts, 40 
mM 2-(N-morpholino)ethanesulfonic acid (pH 5.3), 10 mM glucose, 0.5% (w/v) glycerol and 
100 µM acetosyringone (Winans et al., 1988). AB salts were prepared as a 20X stock (20 g/L 
NH4Cl, 6 g/L MgSO4.7H2O, 3 g/L KCl, 2 g/L CaCl2.2H2O, 0.05 g/L FeSO4.7H2O, pH 7.1). 
Antibiotics were used at the following concentrations: kanamycin, 40 µg/mL; nourseothricin, 
100 µg/mL (liquid) and 200 µg/mL (solid); hygromycin, 50 µg/mL and cefotaxime, 300 μg/ml. 
Stationary phase R. toruloides seed cultures were obtained by inoculating single colonies 
from a YPD agar plate into 2 mL YPD liquid medium. For lipid production, the seed cultures 
were then used to inoculate 25 mL low-nitrogen media with a starting OD of 1, in a 125 mL 
shake flask (Pyrex), and grown at 30°C and 250 rpm. Growth curves were performed in 
duplicate. 
Plasmid and strain construction. All plasmids used in this study are listed in Table 3.1. 
All primers used in this study are listed in Table 3.2. Plasmid for ME over-expression (pGI2-ME) 
was constructed as described: GAPDH promoter was PCR amplified from IFO0880 genomic 
DNA using primers SZ919F/SZ920R. ME and its native terminator was PCR amplified from 
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IFO0880 genomic DNA by primer SZ919F/SZ920R. Vector pGI2 was linearized with AvrII and 
BamHI. These three fragments were ligated by Gibson assembly (Gibson et al., 2009), resulting 
in pGI2-ME. Plasmids for SCD, GPD and PYC over-expression plasmids were constructed in 
similar way, using the same pGI2 backbone and GAPDH promoter.  
For ME and SCD over-expression in RT880-AD background strain, an hygromycin 
plasmid was used. This plasmid, pGI2H was built by Gibson assembly from linearized pGI2 by 
PacI and EcoRI (to get rid of Nourtheorin marker) and hygromycin cassette from pRH2031, PCR 
amplified using primer SZ917F/SZ918R. ME and SCD over-expression cassette were cut from 
pGI2-ME and pGI2-SCD with AvrII and PacI, ligated into pGI2H in the same restriction sites, 
resulting pGI2H-ME and pGI2H-SCD. 
Pex10 deletion plasmid pGI2-del-PEX10 was built as described: 1kb up and down 
homologous flanking PEX10 region were PCR amplified from IFO0880 genomic DNA using 
primer pair SZ934F/SZ935R and SZ938F/SZ939R. Nourtheorin resistance cassette was PCR 
amplified  from pGI2 using primer SZ936F/SZ937R. These three DNA fragments were ligated 
with pGI2 linearized with AscI and EcoRI, by Gibson assembly, resulting pGI2-del-PEX10. 
Agrobacterium tumefaciens mediated transformation (ATMT). pGI2 series of binary 
plasmids were electroporated into A. tumefaciens by standard procedure described in Zhang et 
al.(my paper). These pGI2 series of plasmids were introduced into R. toruloides recipient strains 
by A. tumefaciens described in Zhang et al too. Briefly, A. tumefaciens cells harboring binary 
plasmids were cultured to mid-exponential phase, diluted to OD equals about 1 in induction 
medium for 7 hours in 30°C. Meanwhile, R. toruloides recipient cell were cultured to 
mid-exponential phase and harvested and dilute with YPD medium to OD about 0.6. The A. 
tumefaciens donor and R. toruloides recipient cells were mixed in 1:1 volumetric ratio to a total 
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1 mL. The mixer is filtered through a 0.45 µm filter membrane (Millipore) on a vacuum 
manifold. The filter paper was incubated on an induction medium plate for 2 days in room 
temperature. The cells from the filter paper was washed down in YPD medium and plated onto 
YPD agar plate with cefotaxime, which kills A. tumefaciens, and appropriate antibiotics 
(nourseothricin or hygromycin) to ensure plasmids transformed. Colonies appear in 2-3 days for 
the case of over-expression, and a week for deletion cases.  
Analytical methods. Glucose and xylose concentrations were measured using a 
Shimadzu high-performance liquid chromatography (HPLC) system equipped with a RID-10A 
refractive index detector and an Aminex HPX-87H carbohydrate analysis column (Bio-Rad 300 
mm X 7.8 mm). The column was maintained at 65°C and run with 5 mM sulfuric acid at a flow 
rate of 0.6 ml/min. A cation H micro-guard cartridge (Bio-Rad) was also kept at 65°C. Cell 
growth was measured by the absorbance at 600 nm.  
Lipid weight was determined as follows. A 1 mL liquid culture was harvested and 
immediately frozen at -80°C and freeze-dried in Labconco FreeZone 6 freeze dryer. 1 mL of 
chloroform/methanol (2:1 volumetric) (Folch et al., 1957) was added to the dried sample, and the 
mixture was then homogenized three times at 5 m/s for 30 seconds each, using a FastPrep-24 
homogenizer (MP Biomedicals). The samples were then mixed with 0.2 ml water and vortexed 
for 15 seconds. The organic layer was removed using a Hamilton syringe with a long needle. The 
organic layer was washed with 0.1 mL 0.1% (w/v) NaCl water solution, extracted again, and 
dried in a hood at room temperature overnight in a pre-weighed tube. The tube was further dried 
in an 80°C oven for one hour and then weighed to determine lipid content. Each lipid 
measurement was performed in quadruplet, with two biological replicates and two technical 
replicates for lipid extraction.  
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Dry cell weight was determined as follows. A 2 mL liquid culture was vacuum filtered 
using a pre-weighed 0.45 µm cellulose membrane (Millipore) and then washed with water. The 
filter membranes were dried overnight at room temperature and weighed. Dry cell weight 
measurements were performed in triplicates. 
Fatty acid composition was determined by gas chromatography-mass spectrometry 
(GC-MS). Fatty acids were derivatized using a method from Lepage and Roy (Lepage and Roy, 
1986).  Briefly, extracted lipid was dissolved in 0.5 mL hexanes and 1mL methylation reagent 
(methanol/acetyl chloride 20:1 volumetric) and 2.5 µl internal standard (tridecanoic acid 25 
mg/mL) were added into the mixer. The mixer was incubated in boiling water for 15 minutes 
with occasional mixing in a glass tube with a screw cap. After cooling down in room temperature, 
1 mL water was added and phase separation formed. The upper organic phase was taken out and 
diluted 10 times in hexanes. 2 µl of this diluents was injected into a Shimadzu GCMS-QP2010 
Plus gas chromatograph-mass spectrometer. The samples were run through a Agilent column 
(DM-5S, 30 m X 0.250 mm X 0.25 µm) with helium as the carrier gas. The oven temperature 
started at 50°C, then increased linearly at 10°C per minute and finally held at 250°C for 10 
minutes. Fatty acid methyl esters were quantified by peak area. Samples were in four replicates 
(collected from two biological replicates and derivatized and analyzed in two technical 
replicates) 
mRNA quantification. mRNA were prepared in similar method as in Chapter 2. Primers 
for quantitative amplifying ME, SCD, GPD and PYC were listed in Table 3.2.  
Bioreactor conditions. Seeding cultures were inoculated from YPD plate into YPD 
medium with antibiotics for 48 hours before inoculating into the bioreactors starting at OD600 = 
2. The batch medium consisted of 150 g/L glucose, 8 g/L yeast extract, 0.5 g/L (NH4)2SO4 , 1 g/L 
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KH2PO4, 1 g/L MgSO4. The fermentation was carried in Multifors bioreactors (Infors, Germany) 
with 400mL total volume. Dissolved oxygen was set at 50% with air flow rate 1.25 vvm and 
controlled agitating rate. pH was maintained at 5.6 with 4 mol/L NaOH and 2 mol/L H2SO4.   
Fed-batch fermentation started with 60 g/L glucose, 15.7 g/L yeast extract, 15.7 g/L peptone, 
with 350 mL starting volume. The equivalent of 80 g/L/day final glucose was added into tank by 
injecting 46.7 mL of stock glucose (600g/L) every 24 hours, for 5 times. 40 mL culture was 
drawn out every day for sampling. Fermentation ended at 144 hours.  
 
61 
 
3.3 Results 
3.3.1 Over-expression ME and SCD improved lipid production in R. toruloides wildtype 
control strain.  
In our previous study, we have sequenced two wild type R. toruloides strain IFO0880 and 
IFO0559 and engineered them for improved lipid production (Zhang et al., 2015). We found lipid 
production in IFO0880 based strain surpassed IFO0559 counterparts. Therefore from there on we 
focus on IFO0880 strain. In this study, we aim to boost lipid production by exploring more 
over-expression gene targets to push more carbon flux into lipid biosynthesis. Further we started 
to explore deletion targets to limit lipid degradation pathway as well.  
We chose four over-expression targets in this study, based on the hypothesized lipid 
synthesis pathway (shown in Figure 3.1a) and a handful reports (Dulermo and Nicaud, 2011; 
Qiao et al., 2015): In addition, ME and PYC, theoretically should increase NADPH regeneration 
by the transhydrogenase cycle, which in turn feed into lipid synthesis. Collectively we 
over-expressed these four gene, ME, SCD, GPD and PYC, under the strong GAPDH promoter in 
the binary plasmid pGI2 (shown in Figure 3.1b), transformed into IFO0880 background using A. 
tumefaciens (Abbott et al., 2013; Zhang et al., 2015) yielding RT880-ME, RT880-SCD 
RT880-GPD and RT880-PYC. We confirmed these over-expression by quantitative PCR (shown 
in Figure 3.2a). Indeed, these four genes’ mRNA levels were increased 6-41 fold compared to 
wildtype control RT880-N (IFO0880 transformed with empty pGI2 plasmid). We next sought to 
quantify lipid production for these over-expression strains during shake-flask growth with 70 g/L 
glucose in low nitrogen medium for 9 days. As shown in Figure 3.2b, RT880-ME and 
RT880-SCD showed increased lipid production to negative control RT880-N. Final lipid titers 
were 23.1 % increase for ME and 28.4% for SCD over-expression. RT880-GPD and RT880-PYC 
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didn’t show significant improvement. 
3.3.2 PEX10 gene deletion failed to improve lipid production.  
Targeted gene deletion is challenging in R. toruloides, because non homologous end 
joining (NHEJ) is predominating (Koh et al., 2014). Deletion of KU70, a protein responsible for 
NHEJ, has been reported to increase homologous recombination efficiency in various organism, 
including R. toruloides (Koh et al., 2014; Kretzschmar et al., 2013; Verbeke et al., 2013). Our 
collaborator Dr. Masakazu Ito with Dr. Jeffrey Skerker at UC Berkeley first deleted KU70 by 
flanking a hygromycin cassette with 1 kb DNA fragments up and down stream of KU70 by A. 
tumefaciens mediated transformation. They were able to isolates one out of  four hundred 
colonies to have the correct deletion.  
As choosing deletion target genes for lipid production, we considered PEX10 gene, 
because this is a peroxisome structure gene, deletion of this gene in Y. lipolytica has been shown 
to disrupt peroxisome structure, therefore preventing fatty acids from degradation. We deleted 
PEX10 by the same method, with nourseothricin marker this time. 7 out of 26 colonies were 
correct deletions, according to PCR checks (data now shown). We next tested growth and lipid 
production, again in shake-flask growth with glucose (70 g/L) in low nitrogen medium. As 
shown in Figure 3.3, lipid production did not increase, but rather decreased in PEX10 deletion 
strain (RT880-ΔPEX10). It turned out that the overall biomass growth was repressed in 
RT880-ΔPEX10, compared to its wildtype control strain RT880-ΔKU70 (shown in Figure 3.3, 
dry cell weight). The lipid content of RT880-ΔPEX10 was not higher than the wildtype control 
either (28.9% in RT880-ΔKU70 and 16.9% in RT880-ΔPEX10). Therefore disrupting 
peroxisome function in R. toruloides failed to contribute to lipid production. 
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3.3.3 Applying over-expression gene targets to a previous constructed engineered strain.  
Prior to this study, we have shown that over-expression of acetyl-CoA carboxylase 
(ACC1) and diacylglycerol acyltransferase genes (DGA1) in IFO0880 strain increased lipid 
production by 2 fold in shake-flask cultures (Zhang et al., 2015). So question remains if we can 
combine the previous engineered strain RT880-AD (ACC1 and DGA1 over-expressed) with the 
ME and/or SCD gene over-expression to further improve lipid production. To test it out, we 
over-expressed ME and SCD under GAPDH promoter with a hygromycin resistance marker into 
RT880-AD, yielding RT880-ADM and RT880-ADS respectively. We again confirmed our 
over-expressions by quantitative PCR (Figure 3.4a). The mRNA level of ME and SCD were 
increased 129 and 3.8 fold compared to RT880-AD background. The reason  why SCD gene 
over-expression lever over RT880-AD was not that high is probably due to that the SCD gene 
was already elevated in RT880-AD mutant. We next characterized the lipid production in 
shake-flask growth with glucose (70 g/L) in low nitrogen medium for day 9 days. As shown in 
Figure 4b, SCD over-expression strain (RT880-ADS) demonstrated 18.6 ± 1.3 g/L total lipid, a 
13% increase in lipid final titer compared to RT880-AD, however ME over-expression 
(RT880-ADM) decreased the lipid titer 15%.  The reason why ME over-expression increased 
lipid titer in wildtype control but decreased in RT880-AD strain is unknown. It may implies the 
balance between pathway fluxes. 
Since stearoyl-CoA desaturase (SCD) desaturates stearoyl-CoA into oleoyl-CoA, we 
sought to find out if fatty acid composition changed upon over-expression of this gene. We 
performed fatty acid methyl ester analysis using GC-MS. As shown in Figure 3.5a, in IFO0880 
background strains, over-expression of SCD decreased the stearic acid percentage and increased 
oleic acid percentage over the negative control strains and other over-expression strains (ME, 
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GPD, PYC). For over-expression strain build on RT880-AD, as shown in Figure 3.5b, the 
differences between RT880-AD and RT880-ADS is less than RT880-N and RT880-SCD. This 
potentially is due to the elevated mRNA level of SCD gene in RT880-AD strain, shown in 
Figure 3.4a. Interestingly, RT880-AD strain yielded less C16 fatty acid (palmitic acid), and more 
C18 (stearic acid) and C18:1 (oleic acid), compared to RT880-N. This was also observed in our 
previous study (Zhang et al., 2015). 
3.3.4 Bioreactor demonstration of the over-expression strains.  
Collectively we have shown that combining SCD over-expression with ACC1 and DGA1 
can achieve final lipid titer 212% to IFO0880 wildtype control in shake-flask cultures. Further 
we want to demonstrate the performance of our engineered strains in bioreactor. We inoculated 
RT880-N, RT880-AD and RT880-ADS in batch bioreactor with 150 g/L glucose. As shown in 
Figure 3.6a, glucose consumption rate for RT880-ADS and RT880-AD was faster than RT880-N. 
The final lipid titer in 89 hours in batch bioreactor for RT880-ADS is 27.4 g/L, with the lipid 
content 51%, and a lipid productivity 0.307 g/L/h (shown in Figure 3.5b and tabulated in Table 
3.3). This lipid titer in RT880-ADS is 93% higher than wildtype control strain RT880-N, and 10% 
higher than RT880-AD strain. Because the shortened fermentation time, the lipid production rate 
for RT880-ADS is 3.5 times in RT880-N and 1.2 times in RT880-AD. 
In order to achieve higher lipid titer, fed-batch strategy was employed. The medium and 
feeding methods were adopt from Li et al’s work (Li et al., 2007), with 60 g/L glucose initial 
concentration and 80 g/L/day glucose injection, for five times. The glucose consumption, 
biomass, and lipid titer were plotted in Figure 3.7 and tabulated in Table 3.3. RT880-ADS 
accumulated to 89.4±4.5 g/L at the end, representing 75.6±3.9% lipid content and 0.621±0.031 
g/L/hour production rate and 0.22±0.01 g/g lipid yield. Therefore our triple mutant RT880-ADS 
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showed great potential for high density fed-batch bioreactor cultures for lipid production. 
  
66 
 
3.4 Discussions 
Rhodosporidium toruloides is a great host for lipid-based molecule production, because it 
naturally accumulates large quantity of lipid as dry cell mass (Ratledge and Wynn, 2002) and  it 
consumes variety of carbon sources, such as glucose, xylose, sucrose, glycerol and etc 
(Bommareddy et al., 2015; Xu et al., 2012). In this work we aim to increase lipid production by 
exploring over-expression and deletion genes to drive more carbon into lipid biosynthesis 
pathway. We found by over-expressing malic enzyme (ME) or stearoyl-CoA desaturase (SCD) in 
R. toruloides IFO0880 strain, but not glycerol-3-phosphate dehydrogenase (GPD) and pyruvate 
carboxylase (PYC), we can increased lipid production. Our attempt of reducing lipid degradation 
by deletion PEX10 gene failed to increase lipid production because of the reduced biomass 
growth due to disruption of PEX10.  Further we combined our previously engineered strain 
RT880-AD (IFO0880 over-expressing acetyl-CoA carboxylase (ACC1) and diacylglycerol 
acyltransferase (DGA1) with ME or SCD over-expression and found that SCD can further 
increase lipid final titer to 18.6 g/L in shake-flask culture. We characterized growth and lipid 
production in fed-batch bioreactor and achieved 89.4 g/L lipid titer and 0.621 g/L/hour lipid 
productivity with 0.22 g/g lipid yield with our RT880-ADS strain.  
The triple over-expression of ACC, DGA and SCD was first introduced in Y. lipolytica by 
Qiao et al (Qiao et al., 2015). The SCD’s contribution in Y. lipolytica in addition to ACC and 
DGA double over-expression was about 3.5-5 fold in Qiao’s study. Here in R. toruloides, we 
didn’t observed this scale of increase. This might due to that ACC and DGA over-expression 
already push lipid synthesis close to its limit in R. toruloides. Our RT880-AD in shake flask can 
produce lipid at the yield of 0.266 g lipid per g glucose. The yield for Qiao’s triple mutant’s 
strain is 0.234 g/g. Also, we observed in our RT880-AD strain, the SCD gene already got 
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elevated 2.2 fold, meaning R. toruloides itself regulates the homeostasis of saturated and 
unsaturated fatty acids already, therefore the additional over-expression of SCD didn’t increase 
lipid to what was observed in Y. lipolytica. 
On the other hand, malic enzyme (ME), instead of increasing lipid production as it did in 
IFO0880 background, decreased lipid titer in RT880-AD background. This implies the 
complexity of designing rules for optimizing a pathway. The role of transhydrogenase cycle still 
remains to be further elucidated. Therefore the dosage of each over-expression genes still 
remains to be optimized to balance the fluxes for each pathway.  
Future work includes further exploring other deletion targets. To date the gene knockout 
technique is still challenging, even with ΔKU70 mutant. The homologous recombination 
efficiency in a ΔKU70 background is still gene dependent, ranging from 50% down to 1% in our 
hands. More genetic manipulation techniques are still await to be developed to realize metabolic 
engineering in a more robust way in R. toruloides.  
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3.5 Tables and figures 
Table 3.1. Plasmids and strains list 
Plasmids Genotypes/features Source/references 
pGI2 KanR for bacteria, NatR for yeast, binary plasmid (Abbott et al., 2013) 
pGI2H KanR for bacteria, HygR for yeast, binary plasmid This study 
pRH2031 PGAPDH(880) –eGFP, SpecR for bacteria, HygR for yeast (Liu et al., 2013) 
pGI2-ME pGI2-PGAPDH -ME1-TME1 This study 
pGI2-SCD pGI2-PGAPDH -SCD-TSCD This study 
pGI2-GPD pGI2-PGAPDH -GPD-TGPD This study 
pGI2-PYC pGI2-PGAPDH -PYC-TPYC This study 
pGI2-ΔPEX10 pGI2-UPPEX10-NatR-DOWNPEX10 This study 
pGI2H-ME pGI2H-PGAPDH -ME1-TME1 This study 
pGI2H-SCD pGI2H-PGAPDH -SCD-TSCD This study 
Strains   
IFO0880 Rhodosporidium toruloides strain IFO0880, mating type a NBRC culture 
ll ti   RT880-ME IFO0880/ pGI2-ME This study 
RT880-SCD IFO0880/ pGI2-SCD This study 
RT880-GPD IFO0880/ pGI2-GPD This study 
RT880-PYC IFO0880/ pGI2-PYC This study 
RT880-AD IFO0880/ PGAPDH -ACC1-TACC1-PACL -DGA1-TDGA1 (Zhang et al., 2015) 
RT880-ADM RT880-AD/ pGI2H-ME This study 
RT880-ADS RT880-AD/ pGI2H-SCD This study 
RT880-N IFO0880/pGI2 (Zhang et al., 2015) 
RT880-ΔKU70 IFO0880, ku70::Hyg This study 
RT880-ΔPEX10 IFO0880, ku70::Hyg, pex10:: NatR This study 
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Table 3.2. Primer list 
Primer Sequence Note 
SZ919F 
AACGACGGCCAGTGCCAAGCTTGGCGCGCCTAGGCTGCAGAACTACGCCCTC
TC  
GAPDH promoter 
SZ920R TGTGAGTGATCTGGTGTTGT  GAPDH promoter 
SZ925F TCAGAACAACACCAGATCACTCACAATGCCCTCGACCTTCGCCCCCTCCC  
ME and its 
terminator 
SZ926R 
TTAATTAAGATATCGAGCTCGGTACCCGGGGATCCCGAGCGGAGGATTCTCT
CGACCACC  
ME and its 
terminator 
SZ931F TCAGAACAACACCAGATCACTCACAATGACTGCCTCGTCGGCACTCGAGA  
SCD and its 
terminator 
SZ932R 
TTAATTAAGATATCGAGCTCGGTACCCGGGGATCCAAAGAACGAAGGGGGC
GGGGGCAAG  
SCD and its 
terminator 
SZ929F TCAGAACAACACCAGATCACTCACAATGCCTGCTCAGACCAGCTCAGACG  
GPD and its 
terminator 
SZ930R 
TTAATTAAGATATCGAGCTCGGTACCCGGGGATCCAAGGGAGAGGAAAGCC
GTCTATGAA  
GPD and its 
terminator 
SZ927F  TCAGAACAACACCAGATCACTCACAATGAGCAGGGACGTCACCGCGCTCA  
PYC and its 
terminator 
SZ928R 
TTAATTAAGATATCGAGCTCGGTACCCGGGGATCCAAGAACTGAAGGCGTTT
GTATAGCT  
PYC and its 
terminator 
SZ917F 
AGAGGATCCCCGGGTACCGAGCTCGATATCTTAATTAATTCGTATAGCATAC
ATTATACG  
HYG resistance 
cassette 
SZ918R 
TCACACAGGAAACAGCTATGACATGATTACGAATTCAGATCTTGCTGATAGG
CAGG  
HYG resistance 
cassette 
SZ934F 
TAAAACGACGGCCAGTGCCAAGCTTGGCGCGCCGTGCGACGCCAACGGAGG
ACGC  
PEX10 Up 
SZ935R 
ACACGTCGTCGCAAGGGCTTAATTAACCTAGGCTTCAGCGAAGAGAGTGGGC
G  
PEX10 Up 
SZ938F CGAGAAAGGGCTCTAGAGGATCCGGCTCTCGGACGTCAGTGTTGTAAC  PEX10 Down 
SZ939R 
CACAGGAAACAGCTATGACATGATTACGAATTCCTCCTCCTGTCATTCTCCTG
CTGAC  
PEX10 Down 
SZ936F 
CCCACTCTCTTCGCTGAAGCCTAGGTTAATTAAGCCCTTGCGACGACGTGTG
G  
NAT resistance 
cassette 
SZ937R CGAGAGCCGGATCCTCTAGAGCCCTTTCTCGCGAGCGAGGTTGGC  
NAT resistance 
cassette 
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Table 3.3 Lipid statistics of engineered strain versus wild type control in bioreactor. 
Strain Mode Total lipid (g/L) 
Dry cell 
weight (g/L) 
Lipid content  
(%) 
Lipid production 
rate (g/L h) 
Lipid yield 
(g/g sugar) 
Harvest 
Time 
(h) 
RT880-N Batch 14.2±0.3 31.9±0.6 36.0±1.0 0.088±0.002 0.095±0.002 161 
RT880-AD Batch 24.8±0.7 46.1±7.4 53.9±8.8 0.252±0.005 0.165±0.005 98 
RT880-ADS Batch 27.4±0.7 53.9±2.3 51.1±2.6 0.308±0.008 0.183±0.005 89 
RT880-N Fed-batch 18.0±1.2 69.2±0.6 26.1±1.8 0.125±0.008 0.089±0.006 144 
RT880-AD Fed-batch 62.8±3.1 86.2±2.4 72.9±4.1 0.436±0.022 0.144±0.007 144 
RT880-ADS Fed-batch 89.4±4.5 114.8±0.9 75.6±3.9 0.621±0.031 0.216±0.011 144 
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Figure 3.1 Schematic illustration of pathway and plasmid design. A) metabolic pathway for 
lipid synthesis from glucose. Abbreviations are PYC pyruvate carboxylase; ME, malic enzyme; 
GPD, glycerol-3-P dehydrogenase ; SCD, stearoyl CoA desaturase; PEX10, peroxisome 
biogenesis protein 10; FAS, fatty acid synthase. Gene names in orange indicate the 
over-expression targets in this study. B) plasmid design over-expression (ME). C) plasmid design 
for deletion (PEX10). 
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Figure 3.2 A) mRNA expression level in over-expression strains (OE mutants) versus wildtype 
control (RT880-N). B) RT880-ME, RT880-SCD, RT880-GPD, RT880-PYC and RT880-N 
(IFO0880 wildtype control) strains were cultured in low-nitrogen media with glucose (70g/L) as 
the sole carbon source. 
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Figure 3.3 ΔPEX10 strain’s lipid and dry cell weight compared to its wildtype control 
(RT880-ΔKU70). Grey indicates lipid portion of biomass, white indicates non-lipid biomass. 
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Figure 3.4 mRNA and total lipid of ME and SCD over-expression in addition to ACC1 and 
DGA1 over-expression strain. Relative mRNA expression of ME and SCD from strains 
RT880-N, RT880-AD, RT880-ADM and RT880-ADS as determined by quantitative PCR using 
the actin gene as the internal control. B) Total lipid concentrations after 9 days of growth in 
glucose 70 g/L. (** denotes p<0.01). 
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Figure 3.5 Fatty acid composition measured by GC-MS. A) comparison between single 
over-expression mutants: RT880-N, RT880-ME, RT880-SCD, RT880-GPD, RT880-PYC grown 
in low-nitrogen medium with glucose as the sole carbon source. B) comparison for mutants on 
top of RT880-AD: RT880-N, RT880-AD, RT880-ADM and RT880-ADS. C14: myristic acid, 
C16: palmitic acid, C18: stearic acid, C18:1: oleic acid, C18:2: linoleic acid. 
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Figure 3.6 Bioreactor culture for RT880-N, RT880-AD and RT880-ADS. A) glucose 
consumption starting with 150 g/L glucose in nitrogen limiting medium. B) Optical density at 
600 nm, indicating growth for the three strains. C) Total lipid titer time course. Average of three 
technical replicates (indicated in table 3.3). 
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Figure 3.7 Fed-batch bioreactor culture for RT880-N, RT880-AD and RT880-ADS. A) 
Initial glucose concentration started with 60 g/L , and equivalent of 80 g/L/day glucose were 
injected 5 times total. B) Optical density at 600 nm, indicating growth for the three strains. C) 
Total lipid titer time course. Average of three technical replicates (indicated in table 3.3). 
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Chapter 4: Medium pH influences citric acid and lipid production in Y. 
lipolytica 
4.1 Introduction 
Yarrowia lipolytica is a yeast that can produce both citric acid and lipid. Because of its 
versatile producing capability, it has been an attracting microorganism for the industrial 
production of organic acids, fatty acids, lipid (Alper and Stephanopoulos, 2009; Papanikolaou et 
al., 2002; Xue et al., 2013).  
Numerous studies has revealed the metabolic pathways of how Y. lipolytica produces 
these chemicals: generally under certain nutrient condition (practically nitrogen), isocitrate in the 
mitochondria starts to accumulate, and because isocitrate is in balance with citrate, citrate gets 
exported out of the mitochondria (Evans and Ratledge, 1985; Papanikolaou and Aggelis, 2011). 
From there on citrate can be secreted out of the plasma membrane, resulting in citric acid 
production. Or citrate can be cleaved by ATP-citrate lyase to form acetyl-CoA, which is the 
building block for fatty acids (Boulton and Ratledge, 1981). Fatty acids are later stored in the 
form of triacylglyceride (TAG) for energy storage purpose. Great efforts have been made to 
improve the production of citric acid and lipid separately. Yet how Y. lipolytica regulates which 
way the carbon flows into is not well understood.  
In this study, we begin with showing pH can be an effective tuning parameter for citric 
acid and lipid production in Y. lipoltica, and its effects on the citric acid and lipid are opposite. 
Next we explored the gene expression patterns upon three pHs (pH 2.0, 4,0, 6.0). The pH range 
sits across the three pKas of citric acid and it's the range where citric acid secretion by Y. 
lipolytica varies the most. We didn’t find distinct gene expression changes for the enzymes right 
after citric being cleave into acetyl-CoA. Instead we observed proteins with transporter activities 
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up-regulated in citric acid producing condition. Therefore we propose citric acid transport on the 
plasma membrane in low pH condition is limiting citric acid secretion and in turn diverts carbon 
flow to lipid and other pathways.  
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4.2 Materials and methods 
Strains, media and growth condition. Yarrowia lipolytica W29 strain was used in this 
work. Seeding culture was prepared in YPD medium (yeast extract 10 g/L, peptone 20 g/L and 
glucose 20 g/L). In a bioreactor, the low nitrogen medium was composed of glucose 50 g/L, 
Yeast Nitrogen Base without amino acid and ammonium sulfate 1.7 g/L, Yeast extract 1.5 g/L, 
Ammonium sulfate 1.0 g/L. The pH controlled fermentations were carried in Multifors 2 
(INFORS HT). The culture volume was 450 mL in a 500 mL tank. Temperature was kept at 
30 ℃. Oxygen was kept at 50%, cascade controlled by stir rate. Air was sparged in at 1.4 vvm. 
For the first 17 hours of culture, pH was fixed at 5.0 for all, and then switched to specified values 
until 90 hours. pH was adjusted by 2M H2SO4 and 4M NaOH solutions.  
Analytical methods. Glucose and citric acid concentrations were measured using a 
Shimadzu high-performance liquid chromatography (HPLC) system equipped with a RID-10A 
refractive index detector and an Aminex HPX-87H carbohydrate analysis column. The column 
was maintained at 65°C and 5 mM sulfuric acid at the flow rate of 0.6 ml/min. And a cation H 
micro-guard cartridge (Bio-Rad) kept at a temperature of 65°C. The 5 mM H2SO4 mobile phase 
was pumped at a flow rate of 0.6 mL/min. Peaks were identified and quantified by retention time 
comparison to authentic glucose, citric acid standards.  
Lipid weight was extracted by Folch method and measure as follows. Briefly, a 1 mL 
liquid culture was harvested and immediately frozen at -80°C and then freeze-dried in Labconco 
FreeZone 6 freeze dryer overnight. 1 mL of chloroform/methanol (2:1 volumetric) (Folch et al., 
1957) was added to the dried sample, and the mixture was then homogenized in a FastPrep-24 
homogenizer (MP Biomedicals), with beating speed at 5 m/s for 30 seconds for three times. The 
samples were then mixed with 0.2 ml water and vortexed for 15 seconds. The organic layer was 
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harvested by a Hamilton syringe and washed with 0.1 mL 0.1% (w/v) NaCl water solution, 
extracted again, and the lower organic layer was harvested and dried in a hood at room 
temperature overnight in a pre-weighed tube. The tube was further dried in an 80°C oven for one 
hour and then weighed to determine lipid quantity.  
Dry cell weight was determined as follows. A 2 mL liquid culture was harvested in a 
pre-weighed tube, pelleted and washed with 0.5 mL water twice. The tube with the washed cell 
pellets were dried in the 80°C oven overnight before weighing. Dry cell weight measurements 
were performed in triplicates. 
RNASeq experimental procedure. Total RNA was extracted with RNeasy mini kit 
(Qiagen) as follows. OD of 30 (A.U.*mL) cells were harvested and resuspended in Buffer RLT 
from RNeasy mini kit. 500 μl glass beads (Sigma, acid washed, 425-600 μm) were added and 
homogenized using FastPrep-24, beated at speed 5m/s for 30 sec three times with cooling on ice 
between beating. The cell lysates were purified according to RNeasy mini kit’s protocol “1c. 
Mechanical disruption of cells”. Next, the extracted total RNA were treated with Turbo 
RNase-free DNase kit (Thermo Fisher) according to its standard manual and purified again with 
RNeasy mini kit protocol “RNA clean up”. The stranded RNAseq libraries were prepared with 
Illumina's TruSeq Stranded RNA Sample Prep kit. The libraries were pooled in equimolar 
concentration, and sequenced  for 101 cycles from each single end of the fragments on a 
HiSeq2500 (Illumina). Fastq files were generated and demultiplexed with the bcl2fastq v1.8.4 
Conversion Software. 
RNASeq data analysis. Adaptor sequences and low quality reads were trimmed by 
Trimmomatic (Bolger et al., 2014). The trimmed reads were analyzed by FastQC 
(http://www.bioinformatics.babraham.ac.uk/projects/fastqc/ ). Genome alignments were carried 
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by Tophat2 (Kim et al., 2013). RNA reads were counted by HTSeq (Anders et al., 2015). 
Statistical analysis were carried in R using packages EdgeR, DESeq, GOstats (Robinson et al., 
2010) (Anders and Huber, 2010; Falcon and Gentleman, 2007). Yarrowia lipolytica CLIB122 
genome ASM252v1 was used as the reference genome (Dujon et al., 2004). Gene ontology (GO) 
information of Yarrowia lipolytica was obtained from DOE Joint Genome Institute website. 
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4.3 Results 
4.3.1 Citric acid and lipid production favors opposite pHs  
Oleaginous yeast Yarrowia lipolytica is also a citric acid producing yeast. From a 
production perspective, culture condition should be optimized for individual target compound. 
We found the cultures with or without phosphate buffere showed different citric acid titer in our 
preliminary experiments in shake flasks, while they consumed same amount of glucose (data not 
shown). This triggered us to explore how much pH relates to citric acid production in Y. 
lipolytica. The strain we chose is W29. It is the wildtype version for the po1d, po1f categories of 
auxotroph strains. The latter strains are the background strains for many literatures studying Y. 
lipolytica (Madzak et al., 2000).  
In order to precisely control the pH, we cultured Y. lipolytica W29 in bioreactors in a 
nitrogen limiting medium. To eliminate the pH’s influences to the growth rate, hence the 
different density of culture, we started with the same pH=5.0 for all cultures for the first 17 hours 
before switching pH to different values ranging from 2.0 to 9.0 till glucose was complete. Final 
citric acid titers were compared in Figure 4.1. Citric acid production maximized at pH 6.0 and 
decreased as pH drops to as low as 2.0. We also measured lipid titer and lipid content at pH 2.0, 
4.0 and 6.0, shown in Figure 4.2a and 4.2b. Opposite from citric acid, lipid titer and lipid 
content is higher at pH 2.0 and dropped down at less acidic pHs (4.0 and 6.0).  
We also documented the growth curves for pH 2.0, 4.0 and 6.0 in Figure 4.3. Cell density, 
measured by absorbance at 600 nm and glucose concentration were about the same in the first 17 
hours for all conditions, as expected. After the pH switch, the pH 6.0 culture consumed glucose 
the fastest, followed by pH 4.0 culture, with the slowest pH 2.0 culture. 
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4.3.2 Differentially expressed genes at different pHs.  
To find out whether there are gene expression patterns correlates to different citric acid 
and/or lipid titer, we performed RNASeq experiments for pH 2.0, 4.0 and 6.0 samples at hour 50 
from the bioreactors. For each pH, we sampled from three biological replicates. Since W29’s 
genome sequence is not available, we aligned our read to the Pubmed available CIB122 (Dujon 
et al., 2004) and po1f genomes (Liu and Alper, 2014). We chose to use CLIB122 as the reference 
genome, because 1) CLIB122 have detailed annotations and gene ontology information. The rest 
(W29 and Po1f) do not. 2) The percentage of aligned reads versus total trimmed reads were very 
similar between CLIB122 and po1f (Table 4.1). 3) Since Po1f, which is derived from W29, is 
highly similar to CLIB122 (Liu and Alper, 2014) and our settings for RNASeq tolerate 2 single 
nucleotide variation per 100 base.  
Differentially expressed (P<0.05 and fold change>2) between different pH culture 
conditions were identified. There are 273 genes differentially expressed between pH2 and pH4 
groups, among which 178 genes are higher in pH2 group and 95 are higher in pH 4 group. There 
are 754 genes differentially expressed between pH2 and pH6, with 399 genes higher in pH2 
group and 355 genes higher in pH6 group. There are 128 genes differentially expressed between 
pH4 and pH6, with 51 genes higher in pH4 group and 77 genes higher in pH6 group. Their 
logical set interactions are depicted as Venn diagram in Figure 4.4. We also performed the 
hierarchical clustering, shown in Figure 4.5. From the hierarchical clustering and Venn diagram 
numbers, clearly pH4 and pH6 cells’ transcriptomes have more in common than pH2 cells. 
Within these differentially expressed genes between pH2 and pH6 groups, we found 40 
proteins that have transport activities and are up-regulated in pH6 group. For up-regulated in 
pH2 group over pH6, there are 21 proteins with transport activity. We also found 11 proteins 
85 
 
related to fatty acid metabolism up-regulated in pH2 over pH6, with a few lipases. In the other 
direction there are 2 unregulated proteins with fatty acid metabolism in pH6. For transcription 
factors, we found 11 of them up-regulated in pH6 and 4 being up-regulated in pH2 group. These 
proteins are listed in Table 4.2.  
Between pH2 and pH6 group, we performed gene ontology enrichment analysis on 
highly expressed genes in pH2 group over pH6 group, and found transport activity was 
overrepresented in this group. We did the same analysis on highly expressed genes in pH6 group 
over pH2 group, oxidoreductase activity is overrepresented in this group. We performed similar 
analysis between pH2 and pH4, pH4 and pH6 pair wise, and these results were tabulated in 
Table 4.3-4.5. 
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4.4 Discussions 
Yarrowia lipolytica has attracted great interest as host microorganism for decades, 
originally because its ability to produce citric acid and lipases. In more recent years, it has been 
researched heavily on the potential to produce de novo lipid as well as a model for oleaginous 
yeast (Blazeck et al., 2014a; Qiao et al., 2015; Tai and Stephanopoulos, 2013). In this work, we 
explored how pH in the medium can affect citric secretion and lipid accumulation in the cell. Our 
results suggested near neutral pH promoted citric acid production and suppressed lipid 
accumulation, while acidic pH reduced citric acid and promoted lipid accumulation.  
The citric acid production in relationship to pH in other Y. lipolytica strains has also been 
found in agreement with our discovery (Karasu-Yalcin et al., 2010; Moeller et al., 2007). On the 
other hand, citric acid and lipid relationship has not been revealed explicitly, but insights on 
reducing citric acid and simultaneously increasing lipid can be found in the case like Tai’s 
engineered strain compared to its wildtype (Tai and Stephanopoulos, 2013). From a mass balance 
point of view, 1 g glucose would theoretically yield 1.07 g citric acid; 1 g glucose would yield 
0.274 g lipid, assuming NADPH comes from pentose phosphate pathway (Ratledge, 2014). 
Therefore the citric acid difference (about 25 g/L) between pH2 and ph6 in our bioreactor 
experiments should be exchanged into equivalent of 6.4 g/L lipid. However in our experiments, 
the lipid difference between pH2 and pH6 is around 2.8 g/L. This implies carbon sources had 
diverted into other routes as well, such as the non-lipid biomass for pH2 is 2.4 ± 1.0 g/L, more 
than pH6 group.  
 We aim to explore the transcriptional changes upon pH and try to find correlation 
between citric acid and lipid titer difference to pH. But one thing complicates this study: pH 
change itself is a huge impact on the whole transcriptome. Therefore we only looked at the more 
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extreme changes in gene expression by drawing the line at fold change >2 and p value <0.05. We 
first examined those obvious target enzyme’s expression level. Surprisingly, key enzymes for 
lipid synthesis such as ACL, ACC1, DGA1, DGA2, GPD1 does not fall into the FC>2 
differentially expressed group. Instead we found 3 triacylglycerol lipases, 3 phospholipases being 
upregulated in pH2 (Table 4.6). For reverse side, 1 triacylglycerol lipases, 1 phospholipases is 
stronger in pH6. A holo-(acyl-carrier protein) synthase (YALI0B16082g) and Acyl-CoA oxidase 
4 (YALI0E27654g) is also up-regulated in pH2 over pH6. This indicates in acidic pH, lipid 
turnover is relatively higher than in pH6 group. 
The changes other than transcription upon pH are also possible. Tomaszewska et al  
reported that in a erythritol producing Y.lipolytica strain, with decreasing pH, production of citric 
acid shifted to erythritol production (Tomaszewska et al., 2014). And they found several key 
enzymes’ activities changed upon pH difference. Kavscek el al hypothesized that lipid synthesis 
rate reaches its maximum therefore excess citrate is disposed out of the cell, and can be utilized 
later when needed in Y. lipolytica (Kavscek et al., 2015). They demonstrated this hypothesis by 
slowing down the glycolysis rate and achieved higher lipid yield. This hypothesis does not 
contradict our finding, because our glucose consumption rate is indeed slower in more acidic 
condition (Figure 4.4).  
Our RNASeq data suggest that significant amount of transport activity related proteins 
are enriched (Table 4.3-5). Taken together with the significant citric acid efflux into the medium 
in higher pH, we think this citric acid efflux is possibly mediated by transporters. Kulakovskaya 
et al suggested a plasma transport system for citrate efflux rather than vacuole in Y. lipolytica 
(Kulakovskaya et al., 1993). Anastassiadis and Rehm suggested a pH dependant active transport 
system is responsible for citric acid secretion in Candida oleophila (Anastassiadis and Rehm, 
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2005).  
Citric acid has three pKa : 3.13, 4.76 and 6.40. The intracellular pH is usually near 
neutral (Abbott et al., 2009) . Based on Henderson-Hasselbalch relationship, in pH2 medium, 
Citrate-H3 accounts for 93.5% and Citrate-H2  for 6.5% of total citrate; in pH4 medium, 
Citrate-H3 for 8.1%, Citrate-H2- for 77.7% and Citrate-H2-  for 14.2% of total citrate; in pH6 
medium, Citrate-H2- for 4.1%, Citrate-H2-  for 68.2% and Citrate3- for 27.8 % to total citrate; in 
cytoplasm (assuming pH=7.0), Citrate-H2- for 0.1%, Citrate-H2- for 18.0% and Citrate3- for 81.9% 
of total citrate. The fully dissociated form Citrate3- clearly occupies the majority of intracellular 
citrate, therefore citric acid getting out of the plasma membrane with its undissociated form is 
very unlikely.  The options are that citrate can be transported by symporter or by active 
transporters. Because the evidence that pH drops when Y. lipolytica grows in a pH non-controlled 
shake flask (data now shown) and that sodium hydroxide has to be pumped continuously into the 
bioreactor to maintain pH=6, we reasoned that along with citrate, H+ is also pumped out of the 
cell membrane to maintain electrochemical neutral. This also explains why in acidic pH (such as 
pH2), H+ will be more difficult to be pumped out of the cell since the reverse gradient for H+ is 
much greater than in near neutral pH.  
We lean more to the active transport system than the symporter because symporters 
actively transport a solute at the expense of the downhill of the ion’s gradient. In Y. lipolytica’s 
case, intracellular pH is more basic than extracellular pH, so cells have to pump out proton 
actively too. This is possibly done by H+-ATPase. One of the H+/ATPase (YALI0B22066g), 
which is highly similar to S. cerevisiae PMA1, is found to be 23% greater in pH6 than in pH2, in 
12% greater pH4 than in pH2 (statistically significant). There are also seven proteins have 
ATPase activity up-regulated in pH6 over pH2, although we can’t confirm which ion they 
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transport. We summarized our model in Figure 4.6. The hypothesis is cell secrets citrate through 
some anion transporter (probably in the 40 different transporters tabulated in Table 4.2 (stronger 
in pH6)), and at the same time, transport proton out by proton-ATPase. Because in acidic 
medium, the reverse gradient for pH2 is very high to pump out proton, in order to maintain 
neutral in charge, citrate can’t be secreted out either. The accumulate citrate is therefore pushed 
towards lipid and other pathways. 
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4.5 Tables and figures  
Table 4.1 Percentage of aligned reads from total trimmed reads according to CLIB122 and 
Po1f genomes 
Samples CLIB122 (%) Po1f (%) 
pH2 
78.4 78.5 
83.9 84.0 
87.1 87.1 
pH4 
80.0 80.0 
86.3 86.2 
87.0 86.8 
pH6 
90.3 89.9 
90.9 90.5 
92.9 92.5 
 
 
For each pH group, there are three biological replicates. 
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Table 4.2 Representative differentially expressed proteins between pH2 and pH6 group 
Names Log FC 
Log 
CPM annotation 
Transport related genes (Stronger in pH6 over pH2) 
YALI0A00979g 1.43 7.73 similar to uniprot|P34240 Saccharomyces cerevisiae YKL175w ZRT3 vacuolar membrane protein involved in the regulation of zinc storage 
YALI0A01023g 4.15 8.57 similar to uniprot|Q12691 Saccharomyces cerevisiae YDR038c ENA5 P-type ATPase involved in Na+ efflux 
YALI0A19580g 1.71 5.84 weakly similar to uniprot|P39109 Saccharomyces cerevisiae YDR135c YCF1 glutathione S-conjugate transporter (vacuolar) 
YALI0A21307g 2.55 9.95 similar to uniprot|P25297 Saccharomyces cerevisiae YML123c PHO84 high-affinity inorganic phosphate/H+ symporter 
YALI0B02544g 2.34 5.98 similar to uniprot|Q04182 Saccharomyces cerevisiae YDR406w PDR15 ATP-binding cassette transporter family member 
YALI0B04202g 1.97 8.77 similar to uniprot|P33413 Saccharomyces cerevisiae YHL016c DUR3 urea transport protein 
YALI0B09537g 2.53 6.59 similar to uniprot|Q9URZ3 Schizosaccharomyces pombe Amino-acid permease 
YALI0B12980g 3.30 3.74 to uniprot|Q96VK4 Emericella nidulans ABC transporter protein 
YALI0B13794g 2.20 5.87 similar to uniprot|Q9P7F3 Schizosaccharomyces pombe Ammonium transporter 
YALI0B17930g 2.41 5.51 similar to uniprot|Q12325 Saccharomyces cerevisiae YLR092w SEL2 sulfate transporter P4.33.f3.1 or uniprot|P38359 Saccharomyces cerevisiae YBR294w SUL1 high- affinity sulfate transport protein P4.33.f3.1 
YALI0B19470g 2.92 0.46 similar to uniprot|P36035 Saccharomyces cerevisiae YKL217w JEN1 carboxylic acid transporter protein singleton 
YALI0B19492g 4.06 5.07 similar to uniprot|P19145 Saccharomyces cerevisiae YKR039w Gap1 general amino acid permease 
YALI0B20064g 1.86 5.29 weakly similar to uniprot|P53388 Saccharomyces cerevisiae YPL265w DIP5 dicarboxylic amino acid permease P23.1.f18.1 
YALI0C00451g 5.03 6.75 similar to uniprot|P53388 Saccharomyces cerevisiae YPL265W Dicarboxylic amino acid permease 
YALI0C00495g 1.43 7.31 similar to uniprot|Q12675 Saccharomyces cerevisiae YDR093W Potential phospholipid-transporting ATPase 2 (EC 3. 6.3.1) 
YALI0C04730g 3.79 1.57 similar to uniprot|Q9P702 Neurospora crassa Probable sugar transporter 
YALI0C04796g 1.49 8.43 weakly similar to uniprot|P46996 Saccharomyces cerevisiae YJL163c 
YALI0C16951g 3.42 3.78 similar to uniprot|Q96X51 Pholiota nameko Probable metabolite transporter 
YALI0C20265g 2.40 6.18 uniprot|Q6CBB8 Yarrowia lipolytica YlABC2 
YALI0D00319g 2.59 8.41 some similarities with uniprot|Q08269 Saccharomyces cerevisiae YOL130w ALR1 divalent cation transporter 
YALI0D00363g 3.70 1.92 weakly similar to uniprot|P11636 Neurospora crassa Quinate permease 
YALI0D00759g 5.04 4.86 weakly similar to uniprot|P32804 Saccharomyces cerevisiae YGL255w ZRT1 high-affinity zinc transport protein 
YALI0D01111g 2.88 6.12 similar to uniprot|P39932 Saccharomyces cerevisiae YDR536w STL1 member of the sugar permease family 
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Table 4.2 (cont.)  
YALI0D04873g 2.90 5.78 similar to uniprot|P38929 Saccharomyces cerevisiae YGL006w PMC1 Ca2+-transporting P-type ATPase 
YALI0D06688g 5.50 6.71 similar to uniprot|P40088 Saccharomyces cerevisiae YER145c FTR1 iron permease that mediates high-affinity iron uptake 
YALI0D15422g 2.90 6.52 similar to uniprot|P15380 Saccharomyces cerevisiae YOR348c PUT4 proline and gamma-aminobutyrate permease 
YALI0D19558g 4.66 8.39 similar to uniprot|P32901 Saccharomyces cerevisiae YKR093W Peptide transporter PTR2 (Peptide permease PTR2) 
YALI0D19866g 1.69 6.15 similar to CAGL0I08613g Candida glabrata 
YALI0D23485g 9.96 3.77 weakly similar to uniprot|P32901 Saccharomyces cerevisiae YKR093w PTR2 peptide transporter 
YALI0E00462g 1.71 7.81 some similarities with uniprot|Q08269 Saccharomyces cerevisiae YOL130w ALR1 divalent cation transporter possible transmembrane segments 
YALI0E00748g 7.87 4.33 weakly similar to uniprot|Q12436 Saccharomyces cerevisiae YLR130c ZRT2 low affininty zinc transporter possible transmembrane segments 
YALI0E02156g 1.57 6.57 similar to uniprot|Q99271 Saccharomyces cerevisiae YLR138w NHA1 putative Na+/H+ antiporter possible transmembrane segments 
YALI0E20427g 2.66 8.76 weakly similar to uniprot|P11636 Neurospora crassa Quinate permease (Quinate transporter) 
YALI0E20713g 2.67 7.48 similar to uniprot|P43548 Saccharomyces cerevisiae YFL055w AGP3 amino acid permease 
YALI0E23859g 4.32 -0.33 similar to uniprot|P38361 Saccharomyces cerevisiae YBR296c PHO89 Na+-coupled phosphate transport protein high affinity 
YALI0E24167g 1.92 7.50 weakly similar to uniprot|Q2VQ77 Saccharomyces cerevisiae YPL092w SSU1 Plasma membrane sulfite pump involved in sulfite metabolism and required for efficient sulfite efflux 
YALI0F01254g 2.28 1.63 similar to uniprot|P38971 Saccharomyces cerevisiae YNL270c ALP1 high-affinity permease for basic amino acids 
YALI0F15411g 7.04 4.42 similar to CA4398|CaZRT1 Candida albicans CaZRT1 high-affinity zinc transport protein 
YALI0F19712g 3.17 8.22 Yarrowia lipolytica ADP/ATP carrier protein 
YALI0F25795g 5.19 2.52 similar to uniprot|P50276 Saccharomyces cerevisiae YGR055w MUP1 high affinity methionine permease 
Transport related genes (Stronger in pH2 over pH6) 
YALI0A02244g -1.86 2.67 weakly similar to uniprot|P41948 Saccharomyces cerevisiae YNL142w MEP2 high affinity low capacity ammonia permease 
YALI0A03135g -3.28 4.93 similar to uniprot|P32837 Saccharomyces cerevisiae YDL210W GABA-specific permease (GABA-specific transport protein) 
YALI0A10659g -2.68 5.17 uniprot|Q8J0M2 Yarrowia lipolytica ADP/ATP carrier protein 
YALI0C04411g -1.68 6.59 similar to uniprot|P38925 Saccharomyces cerevisiae YOL122C Transporter protein SMF1/E 
YALI0C06424g -2.35 6.71 similar to uniprot|P10870 Saccharomyces cerevisiae YDL194w SNF3 high-affinity glucose transporter/regulatory protein 
YALI0C10311g -6.93 6.38 to uniprot|P50505 Debaryomyces occidentalis High affinity potassium transporter 
YALI0C15345g -1.39 5.29 to uniprot|P17261 Saccharomyces cerevisiae YCR075c Transmembrane protein ERS1 (ERD suppressor) 
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Table 4.2 (cont.)   
YALI0C15488g -3.63 0.38 similar to uniprot|P36035 Saccharomyces cerevisiae YKL217w JEN1 carboxylic acid transporter protein 
YALI0C16522g -6.34 2.58 similar to uniprot|P39932 Saccharomyces cerevisiae YDR536w STL1 member of the sugar permease family P33.1.f24. 1 
YALI0D00495g -2.10 6.37 similar to uniprot|P32837 Saccharomyces cerevisiae YDL210w UGA4 GABA-specific high-affinity permease 
YALI0D08382g -3.13 1.82 similar to uniprot|P25346 Saccharomyces cerevisiae YCR098c GIT1 glycerophosphoinositol transporter 
YALI0D19008g -2.55 3.63 similar to DEHA0E06105g Debaryomyces hansenii IPF 5370.1 
YALI0E00880g -1.42 5.28 similar to uniprot|O43129 Aspergillus fumigatus MDR2 Multidrug resistance protein 2 possible transmembrane segment 
YALI0E14729g -1.45 5.96 similar to uniprot|P33302 Saccharomyces cerevisiae YOR153w PDR5 pleiotropic drug resistance protein (YlABC1 Yarrowia lipolytica ABC transporter) 
YALI0E23287g -1.93 7.62 to uniprot|P49374 Kluyveromyces lactis High- affinity glucose transporter 
YALI0E23430g -2.86 8.46 similar to uniprot|Q10138 Schizosaccharomyces pombe 
YALI0E32901g -5.46 8.90 similar to uniprot|P36035 Saccharomyces cerevisiae YKL217W JEN1 Carboxylic acid transporter protein homolog 
YALI0F00462g -2.74 3.85 similar to uniprot|O43315 Homo sapiens Aquaporin 9 (Small solute channel 1) 
YALI0F15433g -1.57 3.80 similar to uniprot|P38702 Saccharomyces cerevisiae YHR002w Mitochondrial carrier protein LEU5 
YALI0F24277g -2.02 8.91 weakly similar to uniprot|P49573 Saccharomyces cerevisiae YPR124w CTR1 copper transport protein 
YALI0F25553g -4.03 4.43 similar to uniprot|Q9P702 Neurospora crassa probable sugar transporter 
Lipid related genes (Strong in pH6 over pH2) 
YALI0B09361g 1.65 2.56 uniprot|Q872L3 Yarrowia lipolytica Lipase (EC 3.1.1. 3) 
YALI0D09064g 4.17 1.74 weakly similar to uniprot|Q9P8F7 Yarrowia lipolytica Triacylglycerol lipase precursor 
Lipid related genes (Strong in pH2 over pH6) 
YALI0B16082g -1.48 4.21 similar to Scheffersomyces stipitis holo-(acyl-carrier protein) synthase  
YALI0B16588g -2.16 3.96 similar to uniprot|P07286 Saccharomyces cerevisiae YBR243c ALG7 UDP-N-acetylglucosamine-1-phosphate transferase 
YALI0D08206g -1.56 4.86 similar to uniprot|Q08108 Saccharomyces cerevisiae YOL011w PLB3 phospholipase B (lysophospholipase) 
YALI0D19778g -1.53 6.10 weakly similar to uniprot|Q96U77 Neurospora crassa Conserved hypothetical protein 
YALI0E00286g -3.45 2.32 similar to uniprot|CAD70715 Yarrowia lipolytica LIP7 lipase or uniprot|CAD70716 Yarrowia lipolytica LIP8 lipase possible transmembrane segment 
YALI0E11561g -2.49 2.09 similar to uniprot|CAD70713 Yarrowia lipolytica lipase LIP4 
YALI0E27654g -1.74 7.78 uniprot|O74937 Yarrowia lipolytica POX4 Acyl-CoA oxidase 4 (EC 1.3.3.6), peroxisomal 
YALI0E34507g -1.68 4.22 weakly similar to uniprot|Q9P8F7 Yarrowia lipolytica Triacylglycerol lipase precursor (EC 3.1.1.3) 
YALI0F08217g -1.43 6.74 weakly similar to uniprot|Q08959 Saccharomyces cerevisiae YPL206C Phosphatidyl Glycerol phospholipase C 
YALI0F14113g -2.57 1.50 similar to uniprot|O74207 Candida albicans Phospholipase B 
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Table 4.2 (cont.) 
YALI0F20570g -1.47 4.42 similar to uniprot|P36051 Saccharomyces cerevisiae YKL165c MCD4 sporulation protein 
Transcription factors strong in pH6 over pH2 
YALI0B19602g 3.17 3.19 similar to uniprot|Q9Y7W9 Yarrowia lipolytica Mycelial growth factor-1 
YALI0C10010g 2.16 8.70 weakly similar to uniprot|Q9I1Z7 Pseudomonas aeruginosa O6-methylguanine-DNA methyltransferase 
YALI0D04466g 1.79 9.02 weakly similar to uniprot|Q9Y8B4 Emericella nidulans Positive sulphur transcription regulator METR 
YALI0E11693g 1.77 5.13 similarities with uniprot|Q7S2G7 Neurospora crassa NCU08891.1 predicted protein (40940 - 37571) 
YALI0E16973g 3.22 3.40 some similarities with uniprot|P08153 Saccharomyces cerevisiae YDR146c SWI5 transcription factor 
YALI0E29271g 3.02 5.87 some similarities with uniprot|P54785 Saccharomyces cerevisiae YMR070w HMS1 high-copy suppressor of MOT1-SPT3 synthetic lethality 
YALI0F03388g 1.97 9.41 weakly similar to uniprot|Q9P5L6 Neurospora crassa NCU03905.1 related to AP-1-like transcription factor 
YALI0F05346g 2.67 7.29 weakly similar to uniprot|Q00858 Fusarium solani Cutinase gene palindrome-binding protein 
YALI0F17468g 1.49 6.86 no similarity 
YALI0F17886g 1.46 7.21 some similarities with uniprot|P43574 Saccharomyces cerevisiae YFL021w GAT1 transcription factor for nitrogen regulation 
YALI0F18458g 2.04 8.41 similar to DEHA-IPF8330.1 Debaryomyces hansenii IPF 8330.1 
Transcription factors strong in pH2 over pH6 
YALI0B12716g -1.90 7.94 weakly similar to uniprot|P41546 Saccharomyces cerevisiae YFL031w HAC1 transcription factor singleton 
YALI0C09009g -2.62 0.03 similarities with uniprot|Q9C2Q2 Neurospora crassa Related to transcription activator amyR 
YALI0C09482g -2.80 2.05 similarities with uniprot|Q9C2Q2 Neurospora crassa Related to transcription activator amyR 
YALI0D10681g -3.87 2.41 weakly similar to DEHA0A03135g Debaryomyces hansenii 
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Table 4.3 Enriched genes in the set of differentially expressed genes between pH2 and pH6 
group 
Stronger molecular functions in pH6  
GO_MF_ID   Pvalue  Term  
GO:0005215  2.43E-07  transporter activity  
GO:0022857  4.46E-06  transmembrane transporter activity  
GO:0015075  5.15E-05  ion transmembrane transporter activity  
GO:0022891  1.46E-04  substrate-specific transmembrane transporter activity  
GO:0008509  1.73E-04  anion transmembrane transporter activity  
GO:0015291  3.17E-04  secondary active transmembrane transporter activity  
Stronger molecular functions in pH2  
GO:0008863 7.23E-05 formate dehydrogenase (NAD+) activity 
GO:0016860 8.73E-04 intramolecular oxidoreductase activity 
GO:0016620 9.44E-04 oxidoreductase activity, acting on the aldehyde or oxo group of donors, NAD or NADP as acceptor 
GO:0004190 2.33E-03 aspartic-type endopeptidase activity 
GO:0070001 2.33E-03 aspartic-type peptidase activity 
GO:0016903 2.64E-03 oxidoreductase activity, acting on the aldehyde or oxo group of donors 
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Table 4.4 Enriched genes in the set of differentially expressed genes between pH2 and pH4 
group 
Stronger molecular functions in pH4  
GO_MF_ID   Pvalue  Term  
GO:0046873 5.16E-05 metal ion transmembrane transporter activity 
GO:0005215 7.64E-05 transporter activity 
GO:0015171 3.22E-04 amino acid transmembrane transporter activity 
GO:0046943 5.05E-04 carboxylic acid transmembrane transporter activity 
GO:0005342 5.05E-04 organic acid transmembrane transporter activity 
GO:0008514 7.53E-04 organic anion transmembrane transporter activity 
Stronger molecular functions in pH2  
GO:0016813 0.005203 hydrolase activity, acting on carbon-nitrogen (but not peptide) bonds, in linear amidines  
GO:0042972 0.005203 licheninase activity 
GO:0030414 0.005203 peptidase inhibitor activity 
GO:0061134 0.005203 peptidase regulator activity 
GO:0004553 0.00686 hydrolase activity, hydrolyzing O-glycosyl compounds 
GO:0016798 0.00912 hydrolase activity, acting on glycosyl bonds 
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Table 4.5 Enriched genes in the set of differentially expressed genes between pH4 and pH6 
group 
Stronger molecular functions in pH6 
GO_MF_ID   Pvalue  Term  
GO:0005215 1.99E-10 transporter activity 
GO:0022857 9.13E-08 transmembrane transporter activity 
GO:0015291 3.99E-07 secondary active transmembrane transporter activity 
GO:0008324 3.06E-06 cation transmembrane transporter activity 
GO:0015075 3.36E-06 ion transmembrane transporter activity 
GO:0022891 6.33E-06 substrate-specific transmembrane transporter activity 
Stronger molecular functions in pH4  
GO:0015293 0.000291 symporter activity 
GO:0015294 0.000291 solute:cation symporter activity 
GO:0015291 0.001022 secondary active transmembrane transporter activity 
GO:0008324 0.003879 cation transmembrane transporter activity 
GO:0008733 0.00454 L-arabinose isomerase activity 
GO:0005215 0.00459 transporter activity 
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Figure 4.1 Citric acid final concentration at different pH in bioreactors. Samples were 
harvested at time when glucose finished. Start glucose was 50 g/L. Data were from average of 
three bioreactors replicates.  
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Figure 4.2 Total lipid and lipid content at pH = 2.0, 4.0, 6.0 in bioreactors. Data were from 
average of three bioreactors replicates.  
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Figure 4.3 Growth curve of Y. lipolytica in pH = 2.0, 4.0, 6.0 in bioreactors. A) Glucose 
concentration. B) biomass measured by absorbance at 600 nm. C) citric acid concentration. 
Square, pH at 2.0; circle, pH at 4.0; triangle, pH at 6.0. Data were from average of three 
bioreactors replicates.  
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Figure 4.4 Venn diagram showing differential expressed genes in pH = 2.0, 4.0, 6.0. 
Analyzed by limma package (Ritchie et al., 2015). (Fold change >2, P <0.05) 
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Figure 4.5 hierarchical clustering based on the gene expression pattern at pH = 2.0, 4.0, 6.0. 
Analyzed by flashClust (Langfelder and Horvath, 2012). 
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Figure 4.6 Model for citrate transport at high and low pH. Green transporter: potential anion 
transporters. Purple ellipse: potential proton-ATPase. 
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Chapter 5: Conclusions and future directions 
5.1 Conclusions 
Oleaginous yeasts are attractive microorganism for bio-diesel and other lipid based 
molecules’ production. However genetic tools were not well established, which limit them to 
realize their full potential. Chapter 2 and 3 focus on developing an oleaginous yeast 
Rhodosporidium toruloides as host for lipid production. R. toruloides is one of the highest lipid 
producer within oleaginous yeasts, but genetic engineering is very limited. We successfully 
applied Agrobacterium tumefaciens mediated transformation method to insert heterogeneous 
DNA into its genome. With the genome sequences our collaborators sequenced, we are able to  
functionally over-express genes in R. toruloides. In chapter 2, we applied these genetic tools as 
the first step to demonstrate we are able to improve lipid production 2-fold in shake flask with 
our best engineered strain by over-expressing the native acetyl-CoA carboxylase (ACC1) and 
diacylglycerol acyltransferase (DGA1) . In addition, we also validated a few native constitutive 
promoters for protein expression. In chapter 3, we further explored more candidates for genetic 
engineering. We not only over-expressed genes in the lipid synthesis pathway, but also  
explored deletions in the lipid degradation pathways, although it didn’t result in improvement in 
lipid, because biomass growth was hampered. Further we combined the successful 
over-expression target (stearoyl coA desaturase and malic enzyme) with Chapter 2’s engineered 
strain, and found stearoyl coA desaturase (SCD) was able to improve lipid production an 
additionally 13% on top of ACC1 and DGA1 over-expression mutants in shake-flask, and 
achieved 89.4 g/L lipid in bioreactor with the triple over-expression strain.  
In Chapter 4, we revealed that in a citric acid and lipid producing yeast Yarrowia 
lipolytica, both product formation is dependent on pH. Citric acid secretion favors near neutral 
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pH and lipid favors acidic pH. We performed RNASeq and didn’t find significant overall 
elevated expression in lipid synthesis pathways at low pH when lipid production is favored. We 
proposed a model indicating that transport limits citric acid secretion in acidic pH, because the 
reserve gradient for proton is too high between extracellular pH and intracellular (neutral) pH. 
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5.2 Future directions 
5.2.1 Conditional expression 
Conditional expression is realized by inducible promoters. It’s useful for situation when 
we want to express certain genes at the time point we want, because product may be toxic for 
cell growth, or we want to customize different proteins to be expressed by some orders. Inducible 
promoters are widely used in E. coli, such as lac operon, tet operan, ara operon (Lutz and Bujard, 
1997). In S. cerevisiase, there are also GAL promoter (Mumberg et al., 1994) and also some tetR 
fused promoters (Gari et al., 1997). In Y. lipolytica, Madzek reviewed a list of promoters 
inducible by fatty acids, amino acids, glycerol and etc (Madzak et al., 2004), but these are 
consumables and can’t be used as an industry setting. In R. toruloides, Liu et al. engineered a 
D-amino acid inducible promoters, however it is recommend to use in a DAO knockout strain 
and still inducible lever is influenced by glucose, ammonium and L-amino acid concentration 
(Liu et al., 2015b). Ideally one would like to have an inducible promoter system like what E. coli 
has: tight regulation, high dynamic range and can operate with very low concentration of 
inducers. For future work, tetR system would be tried in R. toruloides or Y. lipolytica. 
5.2.2 Gene silencing  
Knock-down instead of knockout is also a useful tool, because sometimes we can’t 
knockout essential genes, or the genes strongly influencing cell growth. I have considered RNAi, 
and found R. toruloides contains the dicer (RHTO_07042, RHTO_02852) and argonaute genes 
(RHTO_01183, RHTO_06358). I have tried to expressed hairpins sequence (240 bp) of a eGFP 
DNA in a eGFP expressing strain in R. toruloides and antisense of eGFP in eGFP expressing 
strain and  antisense of the pigment producing gene CAR2, but none of them worked.   
Probably the dicer and argonaute system in R. toruloides does not work. We may need to express 
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dicer and argonaute from other yeasts that have been confirmed to work. 
5.2.3 Remove nitrogen dependency 
Now the lipogenesis only occurs when nitrogen is depleted. This is not easy to control. It 
is often a tradeoff between biomass and lipid content. Optimizing nitrogen concentration is 
tedious and is not transferable among different strains. Papanikolaou reported they can make Y. 
lipolytica to produce citric acid when nitrogen source is abundant by deleting 2-methyl-citrate 
dehydratase (Papanikolaou et al., 2013). The inactivation of this gene causes accumulation of 
2-methyl-citrate, which inhibits aconitase, therefore causes citrate to accumulate. Although 
deletion of 2-methyl-citrate dehydratase inhibits cell growth too, this finding is still significant. If 
inactivation of this gene is achieved by an inducible promoter, so it only starts to work after 
growth phases, the system can theoretically remove nitrogen dependency and achieve high titers 
of lipid or citric acid as well.  
5.2.4 Fatty acid secretion  
Fatty acids are stored in TAG in the lipid body in oleaginous yeasts. And 
recovering/extracting from inside these cell are tedious and cumbersome. This is a significant 
problem when it comes to scaling up in a factory. Ideally the product is distributed in the 
supernatant, just like ethanol. After fermentation, the product can be extracted by traditional 
organic solvent extraction. To make fatty acid secreted out of the cell, one need to block fatty 
acyl-CoA from incorporating into TAG and push more fatty acyl-CoA or fatty acyl-ACP 
hydrolyzing into free fatty acid. In addition, blocking fatty acid degradation is probably also 
needed. Next, fatty acid transporters from other species can also be considered.  
5.2.5 CRISPR/Cas9 in R. toruloides  
No need to emphasize more on the importance of CRISPR/Cas9 to genetic engineering. 
108 
 
In R. toruloides, because no replicative plasmid exists as to date, we need to consider alternative 
ways to remove Cas9 activity after it has done the genome processing. One way is to put Cas9 
under a tightly regulated inducible promoter: without adding the inducer, this gene should be 
absolutely dormant in the genome. Alternatively, we could design Cas9 expressing cassette 
inside a pair of loxP sites, and cre is also inside the loxP sites. Cre should be driven by an 
inducible promoter (This inducible promoter does not need to be perfect). Once Cas9 has done 
its work, we can induce cre and then the whole cassette (cre, Cas9 and antibiotic marker) will be 
gone.  
5.2.6 Calculating mass balance 
Lipid yields are always way lower than theoretical maximum. This is very different from 
the ethanol research community. To better understand this problem, one would want to calculate 
exactly how much carbon flow into lipid, non-lipid biomass and secreted substances. We  
would need to know the total extracellular metabolites composition and concentration by LC/MS. 
We also want to calculate the respiration rate, if we can detect the emitted CO2 rate.  We also 
would like to know the elemental composition of non-lipid biomass. With these data, one could 
build a model for where the carbon flows into. And if these information was to be fit into a 
metabolic flux analysis model, perhaps we could get insights into what pathways we can further 
manipulate to increase lipid yield.  
5.2.7 Other value-added products  
Since oleaginous yeasts already produce so much fatty acids, we could start from there, 
and make modifications to fatty acids. We could modify chain length, the number of double 
bonds, the position where the double bonds are; we could hydrolyze these double bonds; we 
could break these double bonds; we could modify the carboxylate group: make esters, or reduce 
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it into alcohols or alkanes. Taken together we could build a consortium of lipid-based chemicals 
and move towards replacing petro-chemical with synthetic biology in the future. 
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